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 REGULATION OF IMMUNOGLOBULIN GENE DIVERSIFICATION BY 
NONCODING RNAs 
 
Grace Teng, Ph.D. 
The Rockefeller University 2009 
 
Small regulatory RNAs supplement the canonical pathways of gene regulation 
through diverse mechanisms of transcriptional, post-transcriptional, and post-translational 
silencing.  These mechanisms range from “classical” RNA interference (RNAi), to gene 
repression by microRNAs (miRNAs), to maintenance of genomic stability by repeat-
associated small RNAs.  Here, I describe the contribution of miRNA-mediated regulation 
to a specific case of gene expression that requires significant somatic alteration of the 
genetic code.   
B lymphocytes perform somatic hypermutation (SHM) and class switch 
recombination (CSR) of the immunoglobulin locus to generate an antibody repertoire 
diverse in both affinity and function.  These somatic diversification processes are 
catalyzed by activation-induced cytidine deaminase (AID), a potent DNA mutator whose 
expression and function are highly regulated.  I show that AID is regulated post-
transcriptionally by a lymphocyte-specific microRNA, miR-155.  I find that miR-155 is 
upregulated in murine B lymphocytes undergoing CSR, and targets a conserved site in 
the 3’untranslated region of the AID mRNA.  Disruption of this target site in vivo results 
in quantitative and temporal deregulation of AID expression, accompanied by functional 
consequences for CSR and affinity maturation.   
 Thus, miR-155, which is known to play important roles in regulating the germinal 
center reaction, does so in part by directly downmodulating AID expression.  Using a 
novel transgenic approach, I have characterized a single miRNA – target pair that has 
functional implications in adaptive immunity and maintenance of genome integrity.  The 
regulation of AID by miR-155 serves as a striking example of two distinct regulatory 
mechanisms – small RNA regulation and somatic gene diversification – converging to 
generate a physiologically beneficial response.   
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CHAPTER 1:  Introduction 
 
1.1  The origins of molecular biology 
 The roots of modern molecular biology sprang from a 19th century monastery 
garden, as an Austrian monk orchestrated meticulous cross-breedings between pea plants, 
and catalogued the transmission of heritable traits through each botanical generation.  
Gregor Mendel’s macroscopic genetic experiments laid the fundamental basis for our 
current understanding of genes and genetics (Mendel, 1866).  Mendel’s original concept 
of “hereditary particles” has evolved through a series of seminal discoveries – the first 
isolation of DNA from living cells (Miescher, 1869), the recognition that DNA carries 
heritable information (Avery et al., 1944; Hershey and Chase, 1952), the description of 
the DNA double helix structure (Franklin and Gosling, 1953; Watson and Crick, 1953; 
Wilkins et al., 1953).  
 The original model for transmission of genetic information, the Central Dogma of 
biology (Fig. 1), was articulated in varying forms by both Francis Crick and James 
Watson (Crick, 1958, 1970; Watson, 1965).  A modern biologist would mostly likely 
superimpose Crick’s concept of information transmission between DNA-RNA-protein 
with an additional layer of multidirectional communication among the biomolecular trio 
generated through gene function and regulation (Fig. 1).  
 Much of gene function can be attributed to protein, which is understandably more 
chemically diverse (and by inference, more functionally diverse) than either of its nucleic 
acid precursors.  However, an astonishing breadth of RNA function has been revealed 
over the last several decades.  In accordance with the central dogma, RNA does indeed 
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function as an intermediary between the DNA code and its final incarnation as protein.  
The biochemistry and behavior of these messenger RNAs (mRNAs), however, inject 
copious amounts of additional information into the cycle of gene expression.  mRNAs 
can undergo editing, alternative splicing, and other co-transcriptional modifications that 
substantially effect the quality and quantity of the encoded protein.   
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1.2  Noncoding RNAs 
 The information-bearing mRNAs are accompanied by a diverse collection of 
noncoding RNAs (ncRNAs), many of which participate in essential housekeeping 
functions.  Well-characterized ribonucleoprotein complexes containing ncRNAs are key 
components of the gene expression infrastructure – functioning from early steps of 
mRNA maturation, all the way to terminal processes of protein export.  The spliceosome 
includes several small nuclear RNAs (snRNAs) that direct mRNA splicing (Black et al., 
1985; Bringmann et al., 1984; Chabot et al., 1985; Lerner et al., 1980; Rogers and Wall, 
1980).  Subsequent translation of these messages relies on decoding by ribosomal RNA 
(rRNA) and transfer RNA (tRNA) in the context of the ribosome.  Yet another class of 
noncoding species, the small nucleolar RNAs (snoRNAs), guide site-specific chemical 
modifications to rRNA, tRNA, and snRNA (Ganot et al., 1997; Ganot et al., 1999; Jady 
and Kiss, 2001; Kiss-Laszlo et al., 1996; Ni et al., 1997; Omer et al., 2000; Tycowski et 
al., 1998).  The influence of ncRNAs also extends to protein export, as the noncoding 
7SL RNA is an integral component of the signal recognition particle (SRP), which 
regulates translocation of secretory and membrane proteins (Walter and Blobel, 1982).  
Chromosomal architecture also depends on ncRNA function; telomerase maintains 
chromosome ends by using an ncRNA component to template the reverse transcription of 
telomeric repeats (Shippen-Lentz and Blackburn, 1990).  Furthermore, ncRNAs can 
actively function as independent catalytic units (Forster and Symons, 1987a, b; Guerrier-
Takada et al., 1983; Kruger et al., 1982; Kuo et al., 1988; Nielsen et al., 2005; Salehi-
Ashtiani et al., 2006; Saville and Collins, 1990; Teixeira et al., 2004), and as direct 
metabolic sensors in bacteria (riboswitches) (Epshtein et al., 2003; Mandal et al., 2003; 
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Mandal et al., 2004; Sudarsan et al., 2003; Winkler et al., 2002a; Winkler et al., 2002b; 
Winkler et al., 2003).  Collectively, these regulatory ncRNAs form the structural and 
enzymatic backbones of several biological processes.   
 It has become increasingly apparent, however, that ncRNA function may extend 
far beyond housekeeping roles.  Recent examinations of transcriptional landscapes have 
revealed an astounding expanse of transcriptional activity throughout mammalian 
genomes, far exceeding the number of protein-coding units (Birney et al., 2007; Okazaki 
et al., 2002).  These transcriptome maps depict an interlaced system of coding and 
noncoding units yielding a considerable population of unannotated, uncharacterized long 
ncRNAs.  Though some of these noncoding transcripts may indeed represent non-specific 
transcriptional noise (Struhl, 2007), recent studies indicate that both the process and 
products of noncoding transcription are likely to be genuinely functional.   
 Bidirectional promoter activity contributes substantially to this pervasive 
transcription.  In yeast, the long noncoding products of this phenomenon have been 
named Cryptic Unstable Transcripts (CUTs) and Stable Unannotated Transcripts (SUTs) 
(Neil et al., 2009; Wyers et al., 2005; Xu et al., 2009).  These ncRNAs emanate from 
nucleosome-free promoters and 3’ termini of protein-coding units.  Promoter-associated 
CUTs and SUTs arise bidirectionally, giving rise to noncoding transcripts that can 
overlap with neighboring mRNAs in either sense or antisense orientations.  A few case 
studies have shown that individual CUTs can mediate transcriptional silencing of 
proximal genes (Berretta et al., 2008; Bird et al., 2006; Camblong et al., 2007; Hongay et 
al., 2006).  The ubiquity and genic association of these CUTs and SUTs in the yeast 
transcriptome hint at a fundamental mechanism of regulating gene expression.  
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 Mammalian transcriptome profiles follow a strikingly similar pattern, with 
clusters of ncRNAs arising at boundaries of transcribed genes.  Long, unstable 
PROMPTs (Promoter Upstream Transcripts) initiate bidirectionally ~0.5 to 2.5 kilobases 
upstream of transcription start sites (Preker et al., 2008).  The genomic addresses of 
PROMPTs are enriched in markers of active transcription, such as RNA polymerase II 
(Pol II) and acetylated histone H3 lysine 9, but do not associate with transcription 
initiation factors that mark coding loci (Preker et al., 2008).  PROMPTs partially overlap 
with distinct class of bidirectional Promoter-Associated Long RNAs (PALRs) (Kapranov 
et al., 2007).  These PALRs initiate proximal to transcription start sites, with the resulting 
ncRNA often overlapping the first exon and intron of the neighboring coding unit.  
Several investigators have also independently identified short (<200 nucleotides) 
noncoding transcripts (of varying size and stability) associated with the 5’ and 3’ termini 
of genes:  antisense Transcription Start Site Associated RNAs (TSSa-RNAs), antisense 
Nuclear Run-on RNAs (NRO-RNAs), bidirectional Promoter Associated Short RNAs 
(PASRs), and Termini Associated Short RNAs (TASRs) (Core et al., 2008; Kapranov et 
al., 2007; Seila et al., 2008).  The promoter-associated subset of these short ncRNAs 
overlaps with PALRs (though not PROMPTs), suggesting that they may represent 
processed versions of long ncRNAs associated with active transcription.  These recent 
discoveries depict a highly active transcriptional landscape, where induction of discrete 
protein-coding genes is accompanied by a flurry of proximal noncoding transcription.  
This system of pervasive genic and intergenic transcriptional activity, inherently 
bidirectional promoters, and widespread polymerase pausing at promoters is not fully 
understood; but has been proposed to alter DNA accessibility, create negative 
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supercoiling to promote transcription initiation, or to poise pools of Pol II molecules for 
rapid activation of associated genes.   
 Recent bioinformatic searches for conserved long ncRNAs indicate that they 
comprise a small but substantial pool of bona fide functional species that are likely to 
regulate many processes (Guttman et al., 2009).  Only a few orphan examples of such 
regulatory long ncRNAs have been characterized – but from these few case studies, a 
startling diversity of regulatory modes have been uncovered.  
 Several of these regulatory long ncRNAs can be broadly categorized as 
modulators of DNA accessibility, several instances of which have been documented in 
yeast.  Low abundance noncoding transcription through promoters of coding genes can 
remodel the chromatin configuration to favor RNA polymerase access.  This read-
through may arise in the same orientation as the coding gene (for example, the fission 
yeast fbp1 locus) or in an antisense orientation (for example, the budding yeast pho5 
locus) (Hirota et al., 2008; Uhler et al., 2007).  The cascade of chromatin disruption 
traveling towards the promoter appears to facilitate polymerase engagement of the coding 
unit.  A similar case of intergenic transcription is proposed to regulate chromatin opening 
at the human β-globin locus (Gribnau et al., 2000).  
 In contrast, other ncRNAs associated with coding loci promote transcriptional 
repression through a variety of mechanisms.  This may take the form of transcriptional 
interference in cis at promoter regions (Osato et al., 2007).  One example of this takes 
place at the SER3 gene in budding yeast.  Noncoding transcription through the upstream 
regulatory region of this gene (producing a ncRNA called Srg1) inhibits the binding of 
transcriptional activators to the promoter, effectively repressing SER3 expression 
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(Martens et al., 2004).  A noncoding transcript initiating upstream of the human 
dihydrofolate reductase (DHFR) promoter mediates transcriptional repression by a 
different mechanism.  This ncRNA forms a stable triplex with the promoter DNA, and 
also interacts directly with the general transcription factor TFIIB to favor disassociation 
of the preinitiation complex from the promoter (Martianov et al., 2007).  This RNA-
dependent repression was also observed when the ncRNA was experimentally supplied in 
trans, indicating that the RNA itself, and not simply transcription, was functionally 
important.  
 Short ncRNA inhibitors of the core transcriptional machinery exist throughout 
phylogeny: the bacterial 6S RNA, the murine B2 RNA, and human SINE-derived Alu 
RNAs (Espinoza et al., 2004; Kettenberger et al., 2006; Mariner et al., 2008; Wassarman 
and Storz, 2000).  These RNAs bind directly to the polymerase, in some cases competing 
with promoter DNA for access to the active site.  In addition to ncRNA inhibitors of 
transcriptional initiation, vertebrates also possess an RNA-based system to negate 
transcriptional elongation.  The elongation factor P-TEFb phosphorylates Pol II to 
generate an elongating transcriptional complex.  Elongation is obstructed, however, when 
the noncoding transcript 7SK binds and represses the kinase activity of P-TEFb (Nguyen 
et al., 2001; Yang et al., 2001).   
 Long ncRNAs also control gene expression through secondary interactions with 
transcriptional co-factors.  The murine developmental program illustrates one such 
mechanism of transcriptional regulation in cis.  The Dlx5/6 homeodomain gene cluster 
(involved in limb patterning and neuronal development) gives rise to an intergenic 
ncRNA, Evf-2, which binds another homeodomain protein (Dlx2) to cooperatively 
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activate Dlx5/6 enhancer activity (Feng et al., 2006).  ncRNA-mediated transcriptional 
repression in cis has also been observed in the cellular response to DNA damage.  
Genomic insults induce noncoding transcription upstream of the mammalian CCND1 
locus, which encodes a cell cycle regulator that is repressed upon DNA damage.  This 
site-specific ncRNA tether recruits the RNA-binding protein TLS, which then inhibits 
histone acetyltransferase activity at the downstream CCND1 gene (Wang et al., 2008).  
Noncoding RNAs need not arise from the same genomic location as their regulated 
targets.  For example, the vertebrate heat shock response exhibits one mode of RNA-
induced transcriptional activation.  A long ncRNA called HSR1 induces the trimerization 
of the heat shock transcription factor HSF1, activating its capacity to stimulate expression 
of downstream targets (Shamovsky et al., 2006).  Trans-acting ncRNAs can also function 
as potent transcriptional repressors.  The human Hox genes, which are responsible for 
developmental body patterning, cluster in several discrete genomic loci.  A recently 
discovered intergenic ncRNA, HOTAIR, originates from the HoxC cluster, but targets a 
distal HoxD gene cluster for Polycomb-mediated epigenetic silencing (Rinn et al., 2007).  
These examples of protein-associated regulatory ncRNAs hint at a vast capacity for 
cooperation between RNA- and protein-based mechanisms of gene regulation.   
 The influence of ncRNA also extends beyond transcriptional processes per se.  
The subcellular trafficking of the transcription factor NFAT (nuclear factor of activated T 
cells) serves as a prime example.  Though the molecular details are not clear, the 
noncoding NRON RNA interacts with nuclear importins, and somehow obstructs the 
ability of NFAT to access its transcriptional targets (Willingham et al., 2005).  
Furthermore, the prevalence of sense and antisense transcript pairs suggests that duplexed 
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RNAs may be a common occurrence in mammalian transcriptomes (Katayama et al., 
2005; Okazaki et al., 2002).  One functional example of overlapping noncoding 
transcription has been described for the human Zeb2 mRNA.  An antisense ncRNA 
intersects with the splice site of its sense mRNA partner, preventing RNA splicing and 
translation of a functional ZEB2 protein (Beltran et al., 2008).   
 Some of the best-characterized ncRNAs have been implicated in epigenetic 
programming and imprinting.  Long noncoding RNAs nucleate two distinct mechanisms 
of dosage compensation (adjustment of the male XY versus female XX chromosome 
inequity).  X chromosome inactivation in female cells of placental mammals stems from 
the mutually exclusive expression of two ncRNAs:  Xist (expressed from the inactive X 
chromosome), and its antisense counterpart Tsix (expressed from the active X 
chromosome).  Xist coating of the inactive X chromosome promotes heterochromatic 
silencing through repressive histone modifications and DNA methylation (Borsani et al., 
1991; Brown et al., 1991; Panning et al., 1997; Panning and Jaenisch, 1996).  In contrast, 
dosage compensation in Drosophila takes the opposite route, where the single male X 
chromosome undergoes hypertranscription, mediated by a ribonucleoprotein complex 
containing the ncRNAs roX1 and roX2 (Ilik and Akhtar, 2009).  A handful of imprinted 
gene clusters are also associated with ncRNAs:  H19 (Bartolomei et al., 1991), Nespas 
(Wroe et al., 2000), Air (Sleutels et al., 2002), Kcnq1ot1 (Pandey et al., 2008) – which 
are believed to participate in the epigenetic silencing of their respective loci.   
 Long ncRNAs represent an expansive class of regulatory molecules that touch on 
multiple aspects of gene expression.  Here, I have discussed only a few functional 
examples that speckle the regulatory landscape.  Given the ubiquity of these RNAs in the 
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transcriptome, there are undoubtedly many more examples and mechanisms of ncRNA 
function to be uncovered.  It remains to be seen how (and if) these few characterized 
ncRNAs relate to the extensive populations of yeast CUTs/SUTs or the mammalian 
PROMPTs and PALRs, and if there are indeed broad classes of ncRNAs that act as 
fundamental genomic regulators.   
 
1.3  Small noncoding RNAs and gene silencing 
In any discussion of ncRNAs, one must inevitably mention small ncRNAs, 
several classes of which have been implicated in transcriptional and post-transcriptional 
gene silencing (Fig. 2).  The earliest signs of these silencing mechanisms were observed 
in petunia plants carrying additional transgenic copies of a pigment biosynthesis gene 
(Napoli et al., 1990).  In an unexpected turn of events, these plants produced flowers with 
variegated pigmentation or even complete lack of color, instead of more vividly-colored 
flowers.  This rather anomalous observation, called “co-suppression,” was later 
recognized as the first phenotypic evidence of a gene silencing mechanism that was also 
observed by others in fungi (Romano and Macino, 1992) and nematodes (Guo and 
Kemphues, 1995).   
 The basis of this phenomenon, termed RNA interference (RNAi), was explained 
in the landmark studies of Fire and Mello, who uncovered a double-stranded RNA-
triggered gene silencing mechanism in C. elegans (Fire et al., 1998).  The molecular 
instigators of this silencing were found to be 21-25 nucleotide RNAs complementary to 
genes undergoing RNAi (Hamilton and Baulcombe, 1999).  These small interfering 
RNAs (siRNAs) are processed from exogenous double-stranded RNAs by the RNaseIII-
11 
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type enzyme Dicer (Bernstein et al., 2001; Hammond et al., 2000; Hutvagner et al., 2001; 
Zamore et al., 2000).  Mature siRNAs then integrate into the RNA-induced silencing 
complex (RISC), and guide the RNA cleavage activity of its Argonaute subunit to a 
complementary mRNA target (Hammond et al., 2001; Liu et al., 2004).  These pathways 
of siRNA biogenesis and silencing have been indentified in fungi, plants, protozoans, and 
animals, representing a well-conserved mechanism of post-transcriptional gene 
regulation.   
In parallel, a related class of genomically-encoded small RNAs was discovered in 
C. elegans (Lee et al., 1993; Wightman et al., 1993).  These microRNAs (miRNAs) in 
their mature form are biochemically indistinguishable from siRNAs, and also engage 
many of the same effector agents as siRNAs.  In contrast to siRNAs, however, miRNAs 
arise from the multi-step processing of endogenous primary miRNA (pri-miRNA) 
transcripts that contain one or more hairpin structures each encompassing a mature 
miRNA sequence (Bartel, 2004).  Distinct ribonucleases in the nucleus (Drosha) and 
cytoplasm (Dicer) trim the hairpin structures into small RNA duplexes (Lee et al., 2003), 
followed by incorporation of one strand of the duplex into an Argonaute-containing 
silencing complex (Hutvagner and Zamore, 2002).   
Plant miRNAs function predominantly as siRNAs, binding with full 
complementarity to their cognate mRNAs and targeting them for endonucleolytic 
cleavage (Llave et al., 2002; Rhoades et al., 2002).  Animal miRNAs, in contrast, are 
believed to recognize mRNA target sequences with partial complementarity, and mediate 
silencing through translational repression (Bartel, 2004), as well as mRNA destabilization 
(Mansfield et al., 2004; Yekta et al., 2004).  The functional variation between plants and 
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animals is thought to reflect two independent evolutionary origins for miRNAs (Axtell 
and Bowman, 2008).  
Though the current miRNA registry is by no means comprehensive, miRNAs 
have been identified in most eukaryotic model organisms, with the exception of S. 
cerevisiae (Griffiths-Jones et al., 2008).  In humans, the known miRNAs number in the 
several hundreds, some with evolutionary conservation reaching back to nematodes and 
arthropods (Griffiths-Jones et al., 2008).  An estimated 30% of eukaryotic genes are 
subject to miRNA regulation (Lewis et al., 2003; Yu et al., 2007), implicating this 
mechanism as a substantial means by which organisms modulate their gene expression 
profiles.  
 Small RNA function also extends to chromatin-dependent and transcriptional 
gene silencing.  These modes of gene repression have been observed in plants, which 
employ siRNAs and miRNAs to direct RNA-dependent DNA methylation and repressive 
histone modifications (Bao et al., 2004; Gendrel et al., 2002; Henderson et al., 2006; 
Zilberman et al., 2003).  Kin of siRNAs and miRNAs also maintain heterochromatic 
silencing of repetitive elements in the genomes of unicellular eukaryotes.  Bidirectional 
transcription of centromeric repeats in fission yeast gives rise to heterochromatic small 
RNAs that recruit an Argonaute-containing protein complex called RITS (RNA-induced 
initiation of transcriptional gene silencing) (Reinhart and Bartel, 2002).  RITS-directed 
histone tail methylation then maintains the silent state of centromere (Verdel et al., 2004; 
Volpe et al., 2003; Volpe et al., 2002).   
 The most recently described small RNA subclass stands apart from siRNAs and 
miRNAs in their size, biogenesis, and expression patterns.  These are the Piwi-interacting 
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small RNAs (piRNAs), 25-31 nucleotide species exclusively expressed in metazoan germ 
cells (Hartig et al., 2007; O'Donnell and Boeke, 2007).  Unlike their more diminutive 
small RNA cousins, piRNAs arise in a Dicer-independent fashion, likely from a single 
stranded RNA precursor transcribed from a piRNA gene cluster (Houwing et al., 2007; 
Vagin et al., 2006).  They partner with the Piwi subfamily of Argonaute proteins to 
silence transposons in the male germline via DNA methylation – their only characterized 
function to date (Aravin et al., 2008).  In addition to silencing parasitic genome elements, 
piRNAs likely play additional roles in mice, whose piRNA repertoire includes a 
substantial subclass not complementary to repetitive transposon sequences (Aravin et al., 
2007).   
 The burgeoning literature on small RNA function reflects on the diversity of tasks 
they perform in nearly all clades of life.  They provide protection against endogenous 
selfish genetic elements as well as exogenous sources of double-stranded RNA.  With 
direct relevance to the formal concept of immunity – plants generate siRNAs from 
invading viral genomes as one component of their antiviral immune defenses (Ding and 
Voinnet, 2007).  The necessity of this mechanism, however, has dwindled in evolution 
with the advent of more complex immune systems.  Furthermore, small RNAs modulate 
the flow of information from DNA to protein through transcriptional and post-
transcriptional silencing mechanisms.  Their influence is apparent throughout 
development and physiological function.   
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1.4  Somatic gene alteration in adaptive immunity 
 Rather than a simple on-off switch, gene expression involves a complex network 
of transcriptional, post-transcriptional, and post-translational regulation.  Thus, enormous 
functional flexibility can be generated from a finite set of coding genes (estimated to 
number around 30,000 (Venter et al., 2001)).  However, the immune system provides a 
striking example where the de facto information content of the genome is not sufficient 
for full biological function.  Vertebrates encounter innumerable pathogenic and 
environmental insults throughout their lifetimes, and thus require a recognition system 
capable of identifying these infinitely diverse particles as non-self.  This demand for 
diversity in recognition certainly exceeds the amount of information that can be encoded 
in the entire genome, much less in one specific locus.   
 The innate immune system induces an immediate and non-specific inflammatory 
response based on recognition of conserved pathogenic motifs such as bacterial 
lipoproteins and viral double stranded DNA.  Specialized cells such as macrophages and 
dendritic cells recognize these invariant motifs via Toll-like receptors (TLRs), triggering 
cytokine and chemokine production and recruitment of additional effector cells.  The 
innate response then gives way to the adaptive response, which hinges on the generation 
of cellular receptors adapted to recognize specific epitopes.  These specialized 
recognition capacities can then be propagated for immunological memory.  B 
lymphocytes manufacture one of these key receptors – the immunoglobulins (Ig), also 
known as antibodies.   
 The requisite diversity of the Ig repertoire is generated in stages, the first of which 
occurs in an antigen-independent manner to create a pre-existing pool of B lymphocytes, 
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each bearing a distinct Ig.  In accordance with Burnet’s clonal selection theory (Burnet, 
1957; Talmage, 1957), antigen-dependent selection then promotes the expansion and 
maintenance of one particular Ig-bearing lymphocyte.   
Over the last half century, the molecular basis of Ig repertoire diversification has 
proven to stem from several elaborate gene rearrangements during B lymphocyte 
development.  The modular architecture of the Ig molecule reveals several opportunities 
for generating both recognition and functional diversity.  Two heavy chain and two light 
chain polypeptides complex into a characteristic Y-shaped configuration. The N-terminal 
prongs of the Y (Variable, or V region) specify the antigen-recognizing capacity, whereas 
the C-terminal stem (Constant, or C region) specifies the effector functions of the 
molecule (Fig. 3).  To achieve the required functional diversity at both the V and C 
regions, the Ig gene locus, occupying some several megabases, undergoes impressive 
molecular acrobatics to facilitate somatic gene alterations during B lymphocyte 
development.  
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 As hematopoietic stem cells commit to the B lineage in the bone marrow, they 
activate transcriptional regulators (E2A, EBF, Pax5) that control the expression of genes 
involved in Ig locus rearrangement (Matthias and Rolink, 2005).  Committed pro-B 
lymphocytes perform the first step of Ig gene diversification when they assemble their Ig 
heavy chain V region genes.  This process, called V(D)J recombination, involves the 
sequential joining of three gene modules – Variable (V), Diversity (D), and Joining (J) – 
to reconstitute a functional V region segment (Fig. 4) (Early et al., 1980; Early et al., 
1979; Maki et al., 1980; Sakano et al., 1981).  Developing T lymphocytes in the thymus 
also undergo an analogous process of V(D)J recombination at the T-cell receptor locus to 
diversify the Variable regions of their cell-surface receptors (Chien et al., 1984; Kavaler 
et al., 1984).  Requiring three-dimensional folding of the DNA, the appropriate V, D, or J 
segments are aligned according to flanking palindromic motifs called recombination 
signal sequences (RSS) (Akira et al., 1987; Sakano et al., 1981; Tonegawa, 1983).  The 
DNA is then recognized and cleaved by the molecular engines of the V(D)J recombinase 
– the Rag1 and Rag2 proteins (McBlane et al., 1995; Schatz and Baltimore, 1988; Schatz 
et al., 1989; van Gent et al., 1995).  Non-homologous end-joining (NHEJ) machinery 
subsequently ligates the appropriate DNA ends (Gao et al., 1998; Grawunder et al., 1998; 
Li et al., 1995; Moshous et al., 2001; Taccioli et al., 1993).   
Productive (i.e. in-frame) V(D)JH recombination allows for the expression of an Ig 
heavy chain, which associates with a surrogate light chain to form the pre-B-cell receptor 
(pre-BCR) (Nishimoto et al., 1991).  As pre-B lymphocytes, these progenitor cells 
perform a second round of recombination at the Ig light chain locus, giving rise to fully 
complexed Ig protein (Reth et al., 1987).  Productive rearrangements result in  
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downregulation of the V(D)J recombination machinery to ensure allelic exclusion 
(Grawunder et al., 1995).  Signaling mediated by surface-expressed Ig on immature B 
lymphocytes will then direct cell maturation, eventually leading to the emergence of 
mature B lymphocytes from the bone marrow.  
A mature B lymphocyte that has undergone V(D)J recombination is then distinct 
from all others at three levels:  1) the random choice of V, D, and J from an extensive 
pool of germline gene segments, 2) the combination of rearranged heavy and light chains, 
and 3) junctional insertions and deletions which occur during rearrangement.  Together, 
this combinatorial and junctional diversity can produce a repertoire of distinct Ig variable 
region specificities in excess of 107.     
Chickens and rabbits employ a slightly different means to diversify Ig specificity 
prior to antigen stimulation.  V(D)J recombination in these animals has limited 
diversification potential, as the Ig heavy and light chain loci harbor few functional V 
region segments.  Furthermore, most of the rearranged V regions preferentially choose 
the same VH gene segment (Knight and Becker, 1990).  Instead, a substantial number of 
nonfunctional V- and J-like pseudogenes are exploited to generate variation through gene 
conversion.  Nucleotides from these pseudogenes are used as templates for sequence 
conversions in the functional, rearranged V region gene (Becker and Knight, 1990; 
Carlson et al., 1990; Reynaud et al., 1985; Reynaud et al., 1987; Reynaud et al., 1989; 
Thompson and Neiman, 1987).  Though V region pseudogenes exist in mouse and human 
genomes, GC does not appear to contribute significantly to primary Ig diversification in 
mammals. 
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  Upon expression of a functional Ig surface receptor, B lymphocytes exit the bone 
marrow and circulate through the bloodstream to the peripheral lymphoid organs, such as 
the spleen, lymph nodes, and Peyer’s Patches of the gut.  These organs collect antigens 
from the mucosal tracts, extracellular fluids, and blood, and present them for sampling by 
the cells of the adaptive immune system.  The germinal centers of these organs provide 
the microenvironments where mature B lymphocytes undergo antigen-dependent 
secondary diversification.  The affinity of the newly assembled V region for its cognate 
antigen is optimized through somatic hypermutation (SHM) of the V region gene (Fig. 4).  
B lymphocytes expressing mutated Igs with high affinity for an antigen preferentially 
receive the strongest survival signals, and are thus selected for propagation into clonal 
populations of Ig-secreting plasma cells and memory B cells.  This SHM-dependent 
process is referred to as affinity maturation.  Secondary diversification also influences the 
effector function associated with a particular Ig.  All B lymphocytes initially express the 
IgM isotype, encoded by the Cµ constant region exons.  Class switch recombination 
(CSR) allows for any assembled V region to be expressed in conjunction with alternative 
C exons to produce other Ig isotypes (IgG, IgE, IgA) with different effector functions.  
This switching is achieved through deletional recombination at the C region locus (Fig. 
4).  The two processes of SHM and CSR cooperate to produce functionally optimized Igs 
with high affinity towards their cognate antigens, and with effector function appropriate 
for the stimulating antigen.   
The three mechanistically dissimilar processes of GC, SHM, and CSR share a 
common molecular trigger – conversion of cytidine to uracil by activation induced 
cytidine deaminase (AID) (Fig. 5) (Arakawa et al., 2002; Muramatsu et al., 2000; 
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Muramatsu et al., 1999).  This enzyme was first identified by Honjo and colleagues, who 
designated it as a novel member of the APOBEC family of polynucleotide cytidine 
deaminases (Muramatsu et al., 1999).  Noting the sequence homology between AID and 
its well-characterized relative, APOBEC1 (an RNA deaminase), it was initially proposed 
that AID edited and activated the mRNA of an SHM- or CSR-catalyzing factor.  Though 
we cannot formally exclude the possibility of AID-mediated RNA editing, the majority of 
experimental observations are consistent with a model of DNA deamination induced by 
AID.  From this DNA-centric perspective of AID function, Ig diversification can be 
understood as the differential processing of AID-dependent lesions in DNA by non-
canonical repair pathways to generate either sequence conversions (GC), point mutations 
(SHM), or DNA recombination (CSR).    
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1.5  Somatic hypermutation, a closer look 
 Joshua Lederberg first proposed that that “genic diversity of the precursors of 
antibody-forming cells arises from a high rate of spontaneous mutation” in 1959, 
predating the breakthrough finding of AID by several decades (Lederberg, 1959).  
Observed mutations at the V region, however, arise at a rate of 10-3 / base pair / 
generation, several orders of magnitude above the rate of spontaneous mutation 
(Lederberg, 1959).  After the discovery of AID, it became clear that AID-mediated 
deamination was responsible for the active mutation and affinity maturation of V regions.   
 Point mutations introduced into the V region are spatially limited to a 1-2 kilobase 
range beginning about 150 base pairs downstream of the Ig V promoter.  Mutation 
frequency also decreases with increasing distance from the promoter (Rada and Milstein, 
2001).  The footprint of mutation coincides strikingly with the footprint of transcription, 
and indeed, SHM has been shown to be intimately linked to transcription (Bachl et al., 
2001; Fukita et al., 1998).  Active transcription bubbles are believed to generate the 
preferred single-stranded DNA substrates for AID deamination.  Storb and colleagues 
posit that a mutator factor (presumably AID) associates with an RNA polymerase II 
transcriptional complex, and deposits mutations as it tracks along the transcribed gene 
(Longerich et al., 2005; Peters and Storb, 1996).  The promoter-distal boundary of 
mutation could then be defined by stochastic dissociation of the mutator from the 
transcriptional complex.  While the concurrence of hypermutation and robust 
transcription is undeniable, the latter is not sufficient.  With a few exceptions (Liu et al., 
2008; Odegard and Schatz, 2006; Pasqualucci et al., 2001), non-Ig genes are not 
hypermutated even when highly transcribed.  An Ig-specific targeting mechanism must 
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exist, but the means of this targeting (Ig-targeted protein co-factors, Ig gene cis-elements, 
differential chromatin accessibility) remains unknown.   
 SHM affects all four bases in DNA, with transition mutations predominant over 
transversions (Golding et al., 1987).  Primary sequence can bias the placement of 
mutations, but in a very limited fashion.  Mutated Cs often associate with canonical AID 
hotspot motifs: WRCY (where W = A/T, R = A/G, and Y = C/T), or its complement 
RGYW (Rogozin and Kolchanov, 1992).  However, these so-called hotspots are not 
absolute determinants of mutability, since not all mutated Cs lie in hotspots.  Strand 
placement can also affect mutability – while C:G base pairs mutate at equal frequencies 
regardless of strand placement (template versus non-template), A:T base pairs mutate 
preferentially when the A is placed in the template strand (34).  This A:T strand polarity 
is not understood, but may stem from asymmetric function of subsequent repair enzymes.   
 AID-mediated conversion of C to U is in itself mutagenic, as simple replication 
over the site (with recognition of U as T) yields transition mutations.  Secondary 
processing of the initiating U:G DNA lesion, however, must occur to generate the full 
spectrum of mutations.  The current paradigm for SHM holds that error-prone versions of  
base excision repair (BER) and mismatch repair (MMR) broadens the range of mutations 
at C:G base pairs and A:T base pairs, respectively (Fig. 6).   
 Uracils occasionally appear in DNA due to stochastic deamination of cytidine or 
misincorporation during replication (Krokan et al., 2002).  Base excision repair (BER) 
removes the unwelcome base using a uracil DNA glycosylase such as UNG, and allows 
for faithful repair of the lesion.  Hypermutating B cells, however, skew the BER pathway 
to facilitate mutation at C:G base pairs.  UNG-mediated cleavage of the uracil base from  
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the DNA backbone creates an abasic site (Di Noia and Neuberger, 2002; Imai et al., 
2003; Rada et al., 2002).  Translesion polymerases then replicate over this non-instructive 
site to generate both transition and transversion mutations (Delbos et al., 2007; Delbos et 
al., 2005; Jansen et al., 2006; Masuda et al., 2005; Zeng et al., 2004).  There is also 
evidence for a complementary pathway of abasic site processing mediated by the 
Mre11/Rad50/Nbs1 (MRN) complex (Larson et al., 2005; Yabuki et al., 2005). 
 AID-mediated cytidine deamination also creates a U:G mismatch that can engage 
the MMR machinery (Wilson et al., 2005).  Mismatch recognition by the MSH2/MS6 
heterodimer is followed by exonucleolytic gap formation and error-prone synthesis to 
generate mutations distal to the initial uracil lesion.  Genetic studies in mice tend to 
support this idea of subverted MMR as a major source of mutations at A:T pairs 
(Bardwell et al., 2004; Delbos et al., 2007; Delbos et al., 2005; Martomo et al., 2004; 
Martomo et al., 2005; Phung et al., 1998; Rada et al., 1998; Wiesendanger et al., 2000; 
Winter et al., 1998; Zan et al., 2001; Zan et al., 2005).  
 Cooperatively, error-prone BER and MMR generate a diverse spectrum of 
mutation at the V region gene.  How these two repair pathways (usually high fidelity) 
detour into the realm of mutagenesis is not well understood.  A recent study proposes that 
the switch between error-free and error-prone synthesis depends on AID activity, where 
Rad6/Rad18-mediated recognition of AID-induced DNA lesions triggers the 
monoubiquitination of proliferating cell nuclear antigen (PCNA), which then 
preferentially recruits error-prone polymerases (Bachl et al., 2006).   
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1.6  Class switch recombination, a closer look 
 In the Ig heavy chain locus, several C region modules lie downstream of the V 
region.  With the exception of Cδ, each set of C region exons is preceded by a repetitive 
G/C-rich DNA element, the switch (S) region.  Nonhomologous recombination between 
two S regions provides the basis of CSR.  The mechanism of CSR exhibits some 
superficial similarities to SHM, namely, transcription dependence, AID dependence, and 
engagement of BER and MMR machinery.   
 At the constant regions, transcription is required in a noncoding capacity.  These 
transcripts initiate from cytokine-inducible, isotype-specific promoters located a few 
kilobases upstream of each S region (Berton et al., 1989; Esser and Radbruch, 1989; 
Gerondakis, 1990; Lebman et al., 1990; Lutzker et al., 1988; Rothman et al., 1990b; 
Stavnezer-Nordgren and Sirlin, 1986; Xu and Stavnezer, 1990) (Fig. 7).  These “germline 
transcripts” do not code for protein, yet appear to play a necessary, but unknown role in 
promoting CSR (Wakatsuki and Strober, 1993; Xu et al., 1993; Zhang et al., 1993).  Two 
additional observations further suggest that RNA-dependent mechanisms may regulate 
the accessibility or targeting of the C regions:  1) splicing of the germline transcripts may 
be necessary for the subsequent DNA recombination (Hein et al., 1998; Lorenz et al., 
1995), and 2) antisense transcription accompanies the sense germline transcription 
(Chowdhury et al., 2008; Perlot et al., 2008). The full significance of these observations 
is not yet clear.  
 Transcription may be key to generating the preferred single stranded DNA 
substrate for AID.  DNA-RNA hybrids, or R-loops, can form upon transcription of G/C-
rich elements such as S regions, thus exposing an unpaired DNA strand for AID 
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deamination (Daniels and Lieber, 1995; Mizuta et al., 2003; Yu et al., 2003).  Though 
AID-dependent point mutations are detected in S regions after CSR (Schrader et al., 
2003), mutagenesis is far from the endpoint of CSR.  Following AID catalysis at S 
regions, CSR proceeds through three stages:  generation of double-stranded DNA breaks 
(DSBs), sensing and synapsis of said DNA breaks, and DNA end-joining (Fig. 7).   
 As in the V regions, AID-induced uracils in both strands of S region DNA are 
recognized and removed by BER to create abasic sites (Rada et al., 2002; Schrader et al., 
2005).  These sites can then be processed by apurinic/apyrimidinic endonucleases (APE) 
to form single-stranded nicks (Guikema et al., 2007).  Two nicks on opposite DNA 
strands, if in close proximity, can destabilize the DNA duplex such that staggered double-
stranded breaks form.  MMR catalyzes an alternative, but minor pathway of DSB 
formation (Bardwell et al., 2004; Ehrenstein and Neuberger, 1999; Ehrenstein et al., 
2001; Li et al., 2004; Martin et al., 2003; Martomo et al., 2004; Schrader et al., 1999; 
Schrader et al., 2007; Stavnezer and Schrader, 2006).  In preparation for end-joining, the 
staggered DNA ends are believed to undergo blunting by either exonucleolytic resection 
of overhangs or short-patch DNA synthesis by error prone polymerases.   
 The broken DNA ends attract canonical DNA-damage sensors such as 
phosphorylated histone H2AX (γH2AX) (Petersen et al., 2001; Reina-San-Martin et al., 
2003), p53 binding protein 1 (53BP1) (Manis et al., 2004; Ward et al., 2004), ataxia 
telangiectasia mutated protein (ATM) (Lumsden et al., 2004; Reina-San-Martin et al., 
2004), and the MRN complex (Difilippantonio et al., 2005; Reina-San-Martin et al., 
2005).  The γH2AX-initiated accumulation of these factors effectively 
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forms a protein scaffold to synapse broken ends from two different S regions that can lie 
up to a hundred kilobases apart. 
The final phase of CSR involves ligation of the synapsed DNA ends.  Given the 
limited homology between different S regions, it is unsurprising that components of the 
nonhomologous end joining (NHEJ) pathway are important for CSR.  Known NHEJ 
factors such as the DNA end-binding complex Ku70/Ku80 (Casellas et al., 1998; Manis 
et al., 1998), DNA-PKcs (Manis et al., 2002), XRCC4 (Soulas-Sprauel et al., 2007; Yan 
et al., 2007) and DNA LigIV (Yan et al., 2007) facilitate efficient CSR.  Mice deficient in 
NHEJ, however, retain some CSR capacity, suggesting the existence of an alternative end 
joining pathway (Han and Yu, 2008; Yan et al., 2007).  Thus in the context of the Ig 
constant region, the composite efforts of DNA deamination, BER, MMR, and end joining 
can link any Ig antigen specificity (defined by the V region) to one of several Ig effector 
functions (defined by the C region).   
 
1.7  Regulation of AID 
 In the ten years since the first identification of AID, our understanding of the 
molecular mechanisms behind Ig gene diversification has expanded immensely.  
Biochemical modification of DNA in B lymphocytes, coupled with slightly off-kilter 
DNA repair mechanisms, yield a diverse cell population that can induce potent cellular 
and molecular defenses based on the recognition of very specific antigenic epitopes.  The 
implications for health are undeniable, as a number of human immunodeficiencies can be 
traced to genetic defects in SHM or CSR components.  For example, mutations in the 
human AICDA or UNG genes lead to hyper-IgM syndrome, characterized by lack of CSR 
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(and sometimes SHM), excessive accumulation of IgM in the serum, and heightened 
susceptibility to infection (Kavli et al., 2005; Revy et al., 2000).   
 Though AID-mediated lymphocyte maturation produces great immunological 
benefits, there are potential hazards to promiscuous AID activity.  Ig gene diversification 
proceeds through highly genotoxic molecular intermediates:  mutations and single 
stranded DNA breaks in SHM, and double stranded DNA breaks in CSR.  Indeed, AID 
does induce oncogenic translocations between the IgH locus and the proto-oncogene c-
myc (Ramiro et al., 2004; Robbiani et al., 2008).  Given such deleterious repercussions on 
genomic integrity, multiple mechanisms are in place to limit AID expression and activity.   
 With a few exceptions (Endo et al., 2008; Komori et al., 2008; Matsumoto et al., 
2007; Pauklin et al., 2009), AID is preferentially expressed in B lymphocytes.  A network 
of essential B lymphocyte transcription factors and cytokine-responsive transcription 
factors demarcate the cell-specificity of AID expression (Dedeoglu et al., 2004; Gonda et 
al., 2003; Park et al., 2009; Sayegh et al., 2003).  A relatively lethargic rate of AID 
catalysis places an intrinsic limit on activity.  In vitro kinetic experiments demonstrate 
that an AID molecule binds to a synthetic single-stranded bubble substrate with 
nanomolar affinity, with the enzymatic consequence of only one deamination every four 
minutes (Larijani et al., 2007).  Such a long-lived AID-substrate complex would be 
consistent with inferences of AID processivity (Larijani et al., 2007; Pham et al., 2003; 
Shen and Storb, 2004) and observations of AID haploinsufficiency (Sernandez et al., 
2008; Takizawa et al., 2008).  
 These fundamental limits on AID expression and activity are supplemented by 
post-translational regulatory mechanisms.  A C-terminal nuclear export signal ensures 
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that AID protein is primarily sequestered in the cytoplasm, thus limiting the amount of 
deamination activity that can access transcriptional substrates in the nucleus (Ito et al., 
2004; McBride et al., 2004).  The protein is further regulated by phosphorylation, which 
does not alter AID catalytic activity, but may instead create docking sites for downstream 
factors involved in SHM or CSR (Basu et al., 2005; Basu et al., 2007; Basu et al., 2008; 
McBride et al., 2006; McBride et al., 2008; Pasqualucci et al., 2006; Vuong et al., 2009).  
AID ubiquitination has also been described, though it remains unclear if this modification 
regulates proteasomal degradation of AID or its interaction with co-factors (Aoufouchi et 
al., 2008).  AID-interacting proteins are proposed to play roles in inter-locus (Ig versus 
non-Ig genes) and intra-locus (V versus C region) targeting, locus-specific assembly of 
multi-protein complexes that differentially promote SHM or CSR (Chaudhuri et al., 
2004; Conticello et al., 2008; MacDuff et al., 2006), or even negative regulation of AID 
to prevent ectopic mutation of non-Ig loci and lymphomagenesis (McBride et al., 2004; 
Ta et al., 2003).   
This combinatorial demarcation of functional boundaries for AID serves as an 
excellent example of the complex information flow generated through gene expression 
and regulation.  I have expanded on this molecular network of AID “supervisors”, with 
the identification of a new contributor to AID regulation:  microRNA-155 (Teng et al., 
2008).   
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CHAPTER 2:  microRNA-155 is a negative regulator of AID 
 
2.1  mIR-155 is upregulated in B lymphocytes undergoing class switch recombination 
 Animal miRNAs predominantly function as fine-tuners of gene expression with 
the capacity for coordinate regulation of groups of genes.  My objective was to identify 
miRNAs that regulate CSR in this manner.  Thus I profiled the miRNA expression 
patterns in naïve and class-switching B lymphocytes by small RNA cloning and 
sequencing.  These data have been catalogued in the smiRNAdb database of tissue-
specific mammalian miRNA expression profiles (Landgraf et al., 2007).  Of the 123 
miRNAs that were cloned from these samples (data not shown), I identified one, miR-
155, that was upregulated after stimulation (Fig. 8a).  By my analysis, this was the sole 
miRNA upregulated in class switching B lymphocytes.  Furthermore, miR-155 was 
upregulated not only in primary splenic B cells treated with LPS and IL-4 (which induce 
switching from IgM to IgG1), but also in CH12-F3 cells, a murine B cell line which 
switches from IgM to IgA after treatment with anti-CD40, IL-4, and TGF-β (Fig. 8b). 
Thus, miR-155 expression is induced during CSR in manner that is not isotype-specific.  
miR-155 is well conserved in the animal lineage, having been identified in sea 
squirts, fish, frogs, and mammals (Griffiths-Jones et al., 2008).  In humans and mice, 
miR-155 is prominently expressed in many hematopoeitic cell types (Landgraf et al., 
2007), and several complementary studies over the last few years have implicated miR-
155 as a key protagonist in diverse immune processes.  However, the details of miR-155 
function in immunity (i.e. its direct targets) had not been described at the time of this 
work.   
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 The gene encoding this microRNA was first identified as a preferential retroviral 
integration site in chicken lymphomas (Clurman and Hayward, 1989).  This novel proto-
oncogenic locus was dubbed bic, for B cell integration cluster (Clurman and Hayward, 
1989).  Retroviral activation of bic was correlated with myc activation and tumor 
metastasis.  Homologs of bic were later identified in mouse and human (Tam, 2001), but 
the functional significance of bic remained unknown for some time, as the gene lacked 
conserved open reading frames.  The most conspicuously conserved feature in the Bic 
RNA was a predicted double-stranded foldback motif, which would later be recognized 
as the precursor hairpin encoding miR-155 (Eis et al., 2005; Tam, 2001).   
Similar associations between Bic/miR-155 expression and certain human B cell 
cancers began to emerge:  Bic/miR-155 is highly overexpressed in lymphomas of 
activated-B cell origin, including Hodgkin’s lymphoma (Kluiver et al., 2005; van den 
Berg et al., 2003) and diffuse large cell B-cell lymphoma (Eis et al., 2005; Kluiver et al., 
2005).  These correlational observations were complemented by the work of Croce and 
colleagues, who created transgenic mice overexpressing miR-155 in B cells (Costinean et 
al., 2006).  These mice developed pre-B cell lymphoproliferative disorders, which later 
progressed to full B cell lymphomas.  These oncogenic effects are not exclusive to the 
lymphoid lineage, as elevated miR-155 expression is also detected in the bone marrow of 
patients suffering from acute myeloid leukemia (O'Connell et al., 2008).  Overexpression 
of miR-155 in hematopoeitic stem cells in the mouse resulted in gross expansion of 
myeloid lineages in the bone marrow and peripheral blood at the expense of erythroid and 
lymphoid populations.  Together, these results reveal the dark side of miR-155 function – 
tandem downregulation of gene set, leading to hyperproliferation and disease.   
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 Despite the oncogenic hazards of deranged miR-155 expression, this microRNA 
has clear utility in the context of healthy innate and adaptive immune systems.  Those 
who first described Bic observed low expression of Bic in hematopoeitic and lymphoid 
organs of healthy chickens, suggesting some kind of inherent function outside of 
oncogenesis (Tam et al., 1997).  As the miRNA field came to prominence, several groups 
noticed that mature miR-155 was induced upon activation of murine myeloid and 
lymphoid cell types (Haasch et al., 2002; O'Connell et al., 2007; Rodriguez et al., 2007; 
Teng et al., 2008; Thai et al., 2007; Tili et al., 2007).  Mice deficient in miR-155 show 
clear defects in Ig production and maturation, exhibiting reduced overall titers of serum 
Ig, and specifically, decreased titers of high-affinity and class-switched hapten-specific Ig 
(Rodriguez et al., 2007; Thai et al., 2007; Vigorito et al., 2007b).  These B-lymphocyte 
defects, along with faulty antigen presentation by dendritic cells and disturbed T 
lymphocyte maturation, contributed to the complex immunodeficiency exhibited by the 
miR-155-deficient animal, which was unable to generate immunological memory, and 
could not protect itself from repeated infections with the same pathogen (Rodriguez et al., 
2007).  Transcriptome profiling revealed that approximately 60 putative miR-155 target 
genes were upregulated in these mice compared to wild type counterparts (Vigorito et al., 
2007b).  At the time of this work, however, none of these potential targets had been 
specifically characterized with respect to miR-155 regulation and Ig maturation.   
 
2.2  miR-155 targets the 3’UTR of AID mRNA 
 Since I had observed miR-155 induction in class-switching B lymphocytes, my  
next objective was to understand how miR-155 contributes to Ig diversification.  I applied 
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several miRNA target prediction algorithms (PicTar (Krek et al., 2005), miRanda 
(Griffiths-Jones et al., 2006; John et al., 2004), and TargetScan (Grimson et al., 2007; 
Lewis et al., 2003)) to identify putative targets of miR-155 with relevance to either SHM 
or CSR.  These prediction algorithms tend to return copious lists of putative miRNA 
targets, but AID was consistently predicted as one such target.  Furthermore, the stringent 
prediction criteria of the TargetScan algorithm (Grimson et al., 2007) identified miR-155 
as the sole miRNA target site in the AID 3’UTR.  The 3’UTRs of AID mRNA diverge 
substantially in sequence and length between various species (Fig. 8c).  However, they 
coincide strikingly at an 8 nucleotide motif corresponding to the predicted miR-155 target 
site seed region.  To test the possibility of post-transcriptional AID regulation by miR-
155, I created reporter constructs containing the 3’UTR of AID downstream of a firefly 
luciferase reporter gene (Luc-UTR), along with variants harboring deletion (Luc-del-
UTR) or mutation (Luc-mut-UTR) of the miR-155 target site (Fig. 8d).  These constructs 
were transiently transfected into CH12-F3 cells stimulated to undergo CSR (and hence 
induced to express endogenous miR-155).  I observed repression of luciferase activity by 
~50% in cells transfected with Luc-UTR compared to cells transfected with a luciferase-
only construct (Fig. 8e).  This repression was alleviated upon disruption of the miR-155 
target site by deletion or mutation.  These data indicate that the single target site in the 
3’UTR of the AID mRNA renders it susceptible to repression by physiological levels of 
miR-155 expressed during CSR.   
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2.3  Mutation of the AID miR-155 target site results in deregulated AID expression 
and increased CSR 
 To study the behavior of in vivo AID expression in response to miR-155, I took 
advantage of a recently generated transgenic AID-GFP indicator mouse strain (Crouch et 
al., 2007). These mice carry a 75 kilobase-long BAC that contains the entire AID locus as 
well as its two adjacent gene loci (Mfap5 and Apobec1). The AID locus in this BAC has 
been modified such that the gene encoding GFP is inserted immediately downstream of 
the coding portion of the final AID exon (Fig. 9a).  The transgenic AID-GFP fusion 
protein expressed from this BAC was previously shown to replicate endogenous patterns 
of AID expression (Crouch et al., 2007).  The AID-GFP protein also retains catalytic 
activity, as it can rescue in vitro CSR in AID-/- B lymphocytes (data not shown).  Based 
on this published AID-GFP BAC, I created a second transgenic construct in which the 
miR-155 target site seed region was mutated to disrupt binding to miR-155 (AID-GFP-
Mut) (Fig. 9a). This second construct was used to generate five independent founder lines 
carrying the AID-GFP-Mut BAC transgene. 
 Splenic B lymphocytes from progeny of these transgenic founders were analyzed 
for AID-GFP expression in response to in vitro stimulation with IL-4 and LPS.  The 
dynamics of AID-GFP expression differed considerably between the AID-GFP control 
and AID-GFP-Mut mice.  The controls exhibited a gradual increase of low intensity AID-
GFP fluorescence with time of stimulation (as also observed in (Crouch et al., 2007)), 
mirroring the expression profile of endogenous AID.  In contrast, cells from AID-GFP-
Mut mice showed a rapid induction of AID-GFP, peaking early around day 3, then 
reaching a plateau (Fig. 9b).  The median intensity of AID-GFP fluorescence was also 
42 
43 
44 
higher in the AID-GFP-Mut mice, suggesting more abundant AID-GFP protein, 
compared to controls (data not shown).  Similar trends were also observed for AID-GFP 
mRNA, suggesting that miR-155 could regulate AID mRNA stability and protein 
translation (Fig. 9c).  My results demonstrate that in vivo disruption of the AID miR-155 
target perturbs the quantitative and temporal expression characteristics of AID. 
 These disparities were not due to position effects due to differential integration of 
each BAC transgene since large BACs are not susceptible to overexpression due to 
random insertion in active expression sites (Gong et al., 2003; Hatten and Heintz, 2005).  
Furthermore, I screened multiple independent AID-GFP-Mut founder lines, and also 
controlled for copy number variation by comparing animals with similar transgene copy 
numbers – in all instances yielding identical results (data not shown).  
 To assess the functional consequences of miR-155 target site disruption, the AID-
GFP control and AID-GFP-Mut mice were bred onto an AID-/- background to extinguish 
the contribution of endogenous AID.  I first compared in vitro CSR efficiency by 
stimulating splenic B lymphocytes from these mice using LPS (to induce CSR to IgG3), 
LPS and IL-4 (to induce CSR to IgG1), or LPS and IFNγ (to induce CSR to IgG2a).  
AID-/- B cells perform negligible in vitro CSR (data not shown). I observed increased 
CSR in the AID-GFP-Mut mice compared to AID-GFP control or wild type mice (Fig. 
9d).  This was the case regardless of whether these BAC transgenics were deficient or 
heterozygous for AID in the endogenous locus (Fig. 9d). These results indicate that miR-
155 directly regulates AID expression in stimulated B lymphocytes. 
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2.4  Mutation of the miR-155 target site leads to local but not global deregulation of 
AID in vivo 
 To study in vivo effects of disrupting the AID miR-155 target site, the transgenic 
mice were immunized intraperitoneally with nitrophenol conjugated to chicken gamma 
globulin (NP-CGG). The NP hapten induces a well-characterized immune response in 
peripheral lymphoid germinal centers (GC), where activated lymphocytes undergo Ig 
diversification (Cumano and Rajewsky, 1985; Furukawa et al., 1999; Taketani et al., 
1995).  Eighteen to 21 days after immunization, I evaluated AID-GFP expression by flow 
cytometry in various B lymphocyte subsets.  Mutation of the miR-155 target site did not 
disrupt global transcriptional control of AID: immature CD93+ B lymphocytes in the 
bone marrow, along with thymic and peripheral CD4+ or CD8+ T lymphocytes were 
devoid of AID-GFP (Fig. 10).  However, AID-GFP was detected in B cell populations 
associated with activation.  GC B lymphocytes (CD95+ B220+) from spleen and intestinal 
Peyer’s patches expressed AID-GFP in both the control and AID-GFP-Mut mice.  The 
latter, however, showed far more intense GFP fluorescence, indicating a similar 
overabundance of AID-GFP during the GC reaction, as observed during in vitro CSR 
(Fig. 11a).   
 After completing the GC reaction, activated B lymphocytes exit into the periphery 
and differentiate into plasma or memory cells.  These post-GC B lymphocytes cease to 
express AID (Crouch et al., 2007).  Accordingly, the AID-GFP control mice did not 
express AID-GFP in B cells in the peripheral blood (Fig. 11b).  In contrast, a GFP+ 
population of B cells was consistently detected in the blood of immunized AID-GFP-Mut 
mice (Fig. 11b).  These appeared to be a heterogeneous population of B lymphocytes  
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(B220int-hi), which were mostly IgG1+ but also included IgM+ and IgD+ non-switched 
cells.  This B lymphocyte population did not appear to arise ectopically as a consequence 
of AID-GFP overexpression, as a similar B220int (though GFP–) population was also 
present in the AID-GFP controls.  Thus, disruption of the AID miR-155 target site allows 
for improper persistence of AID-GFP expression beyond the GC compartment.  These 
results confirm once again that the phenotypes I observed cannot be explained by BAC 
copy number variation, which could be expected to increase protein expression but 
cannot lead to persistent expression in cells where the gene of interest is normally shut 
off.  My data strongly support the idea that miR-155 controls AID expression levels and 
specifically, plays a pivotal role in extinguishing AID expression in post-GC B cell 
populations. 
 
2.5  Loss of miR-155 regulation of AID results in impaired affinity maturation 
 To determine the functional impact of defective AID downregulation, I compared 
affinity maturation of NP-binding IgG1 in sera collected at 8 days and 19 or 21 days after 
immunization.  The ELISA capture substrate was NP conjugated to BSA in different 
ratios to detect high-affinity (NP3-BSA) and total (NP30-BSA) immunoglobulins (Ig) 
specific for NP.  Affinity maturation was measured as the NP3:NP30 -binding ratio.  As 
expected, I observed an increase in the proportion of high-affinity Ig from day 8 to 
day19/21 in control AID-GFP mice.  However, affinity maturation was significantly 
impaired in AID-GFP-Mut animals (Fig. 12).  
 To ascertain if the observed affinity maturation defect resulted from AID-GFP 
overexpression in GCs, I analyzed the mutation load at Ig loci in CD95+ GC B  
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lymphocytes.  After sequencing the VH186.2 gene segment, which is selected for during 
the Ig response against NP (Cumano and Rajewsky, 1985) (to assess the mutation profile 
under selection) and the JH4 intron (to assess the mutation profile in the absence of 
selection pressure), I found that the frequencies and overall patterns of mutation did not 
differ substantially between AID-GFP and AID-GFP-Mut mice (Table 1). Thus, I 
considered two possibilities:  either the repair mechanisms that process AID-mediated 
lesions are not overwhelmed by higher lesion loads, or excess AID was not specifically 
targeted to the Ig locus.   
 Aside from the Ig genes, a number of other genes, including the oncogene Bcl6, 
have been shown to hypermutate in germinal centers (Pasqualucci et al., 2001; Shen et 
al., 1998).  I reasoned that excess AID mutational activity, if not targeted to the Ig genes, 
could instead be targeted to these other non-Ig loci.  To test this hypothesis, I cloned and 
sequenced Bcl6 from GC B lymphocytes of NP-immunized AID-GFP and AID-GFP-Mut 
mice.  I found that Bcl6 from AID-GFP GC B cells was mutated with a frequency of 0.17 
x 10-3 per base (similar to reported Bcl6 mutation frequency in murine GC B cells from 
Peyer’s Patches (Muto et al., 2006) (Table 1).  In contrast, Bcl6 from AID-GFP-Mut GC 
B lymphocytes mutated about three times as frequently (0.46 x 10-3 per base) (Table 1).  
This observation supports the hypothesis that excess AID activity within the GC is 
distributed to non-Ig targets for hypermutation, suggesting that loss of miR-155-mediated 
downregulation of AID could result in higher rates of AID-dependent translocation or 
lymphomagenesis.   
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Table 1.   In vivo mutation frequencies in AID-GFP and AID-GFP-Mut mice 
 
Genotypea VH186.2 JH4 intron Bcl6 
AID-GFP 31.8 6.8 0.17 
 (394/12,400)b (79/11,600) (7/41,600)c 
    
AID-GFP-Mut 30.7 5.5 0.46 
 (800/26,000) (101/18,400) (18/39,000) 
aMutation data are pooled from two animals 
b(number of point mutations / total nucleotides sequenced) 
cChi square test, P=0.0306 
 
Mutation frequencies x 10–3 per base (accumulated number of mutations in a given region 
divided by the total number of nucleotides sequenced from that region) are shown for 
VH186.2, JH4 intron, and Bcl6 from splenic GC B cells in NP-immunized AID-GFP and 
AID-GFP-Mut mice.   
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Table 2. Clonal variability in post-GC B lymphocytes of AID-GFP and AID-GFP-Mut 
mice 
 
Genotypea # unique clones / total Intraclonal mutation 
frequency x 10-3 
%W33L or Y99Gd 
AID-GFP 9/50c 0.55 (11/20,000)b 63 
    
AID-GFP-Mut 36/80c 0.87 (34/39,000) 18 
aMutation data represent unique clones pooled from four animals 
b(number of point mutations / total nucleotides sequenced) 
cFisher’s exact test for the indicated data sets, P=0.043 
dW33L and Y99G are substitutions associated with high affinity 
 
 
Clonal variability is expressed in terms of clonal mutations in the JH4 intron and amino 
acid substitutions associated with NP antibody affinity maturation. 
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  However, these data did not explain the loss of affinity maturation observed in the 
AID-GFP-Mut mice.  I then asked if continued mutation outside of the GC (due to 
persistent AID-GFP expression in post-GC B cells) could account for this phenotype.  To 
test this possibility, I cloned and sequenced the JH4 intron from post-GC lymphocytes  
from peripheral blood of AID-GFP and AID-GFP-Mut mice.  I found that B lymphocytes 
from the blood of AID-GFP mice comprised a small number of highly related and 
affinity-matured clones, with some intraclonal heterogeneity (Table 2).  This is not 
surprising, as post-GC B cell clones in the blood have undergone stringent positive 
selection for those producing high-affinity Ig.  In contrast, I found a higher number of 
unique post-GC B lymphocyte clones in the blood of AID-GFP-Mut animals.  Because 
these clones were so heterogeneous, I could not conclusively ascertain if the mutational 
load per unique clone was higher in comparison to those from the blood of AID-GFP 
mice (i.e., whether these cells were continually mutating their JH4 intron).  However, in 
agreement with the serum data, these clones did not appear to have acquired the amino 
acid substitutions associated with high affinity NP antibodies (notably the W33L 
substitution or the Y99G substitution (Furukawa et al., 1999)).  Two non-mutually 
exclusive explanations could account for these results:  1) selection remains intact in the 
GC to allow for emergence of high affinity B lymphocyte clones, but continued mutation 
in the outside of the GC diminishes the affinity of the previously-selected clones, or 2) 
overabundant AID expression in the GC somehow disturbs the process of selection, and 
allows the escape of low affinity Igs from the GC.   
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2.6  Discussion 
Although hundreds of miRNAs are present in the mammalian genome, genetic 
studies addressing their physiological roles are at an early stage.  Here, I address the 
function of miR-155 in the context of antibody diversification by identifying this 
particular miRNA as upregulated in B cells undergoing CSR, by bioinformatically 
identifying AID as a putative target, and by genetically mutating the target sequence in 
the 3’UTR of the AID mRNA to allow the resulting mRNA to escape miR-155 control.  
These experiments were the first to identify a target of a miRNA in vivo, not by 
manipulating expression of the miRNA itself, but rather, by genetically disrupting the 
association between a miRNA and its target.   
 Most miRNA-targeted mRNAs contain multiple predicted target sites for several 
different miRNAs.  Deletion of just one of these targeting miRNAs can result in target 
upregulation in a dose-dependent manner, leading to the hypothesis that multiple 
microRNAs synergistically fine-tune the expression of a single target gene (Xiao et al., 
2007).  There is also a remarkable degree of regulatory cooperativity between closely-
spaced microRNA target sites (Grimson et al., 2007).  Surprisingly, stringent target site 
predictions for the AID 3’UTR identify only a single miRNA target site complementary 
to miR-155.  Mutating the seed region of this site leads to dramatic RNA and protein 
overabundance and disruption of proper temporal downregulation.  My observations are 
consistent with the miR-155-/- mouse phenotype [reported by two independent groups as 
my own work was in progress (Rodriguez et al., 2007; Thai et al., 2007)], which also 
featured increased AID expression (though to a lesser degree than observed in my 
transgenic mouse model) (Vigorito et al., 2007a).  The behavior of the transgenic AID-
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GFP-Mut RNA and protein strongly supports a model in which miR-155 directly 
downregulates AID expression.  In this particular case, AID protein amounts and activity 
are already limited by haploinsufficiency combined with multi-factorial regulation.  
Superimpose this regulatory network with a “subtle” suppressor such as miR-155, and the 
effects of a single miRNA could be far more substantial than anticipated.  One could 
imagine a very fine tipping point between AID expression and repression, and 
temporally, miR-155 could provide the regulatory impetus that biases the system towards 
extinguishment, ensuring an optimal immune response.   
 Ablating miR-155 control of AID expression led to increased RNA and protein 
expression in switching cells, which underwent significantly higher levels of CSR.  The 
de-repressed AID-GFP protein in germinal center lymphocytes, however, did not produce 
elevated SHM frequency in the Ig locus, instead causing increased hypermutation of a 
non-Ig locus, Bcl6.  This is consistent with previous work by Honjo and colleagues (Muto 
et al., 2006), who likewise showed that transgenic AID overexpression does not lead to 
an increase in SHM.  One can infer from these combined results that: 1) there are 
fundamental differences in targeting of AID to the V region genes versus the C region 
genes, and 2) SHM may involve a limiting factor that shields potential deamination 
targets in the Ig locus from excess AID activity.   
 Excess AID is likely to increase the rates of chromosomal translocations 
associated with errant hypermutation (Dorsett et al., 2008; Ramiro et al., 2006; Ramiro et 
al., 2004).  In the absence of miR-155 control, AID overexpression may be causal for B 
cell lymphomagenesis.  Indeed, Kluiver et al. have recently documented a lack of miR-
155 expression in primary cases of B cell Burkitt lymphomas, which constitutively 
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express AID (Kluiver et al., 2006).  
In addition to overabundance of AID, I have shown that lack of miR-155 control 
leads to persistence of AID expression in post-germinal center B cells, effectively 
marking a unique subset of circulating B cells as recent emigrants from the germinal 
center.  I also find that persistent AID expression is associated with specific defects in 
affinity maturation.  It is possible that persistent AID expression supports ongoing 
mutation in the Ig locus well after cells exit the germinal center with an affinity-matured 
antigen receptor, effectively destroying the properly selected Ig repertoire.  However, one 
might expect to observe a much larger increase in clonal heterogeneity in peripheral B 
cell populations, if this were the case.  Alternatively, my observation of multiple low-
affinity B cell clones in the blood of AID-GFP-Mut animals could suggest a defect in 
positive selection of properly matured B cells.  Though the mechanisms of positive 
selection and affinity maturation are not well understood, it is thought that B lymphocytes 
cycle between the dark zone of the germinal center, where mutation occurs, to the light 
zone, where their newly minted receptors are substrates for positive selection.  
Eventually, B cells bearing high-affinity Igs are thought to emerge after multiple rounds 
of recycling through the germinal center.  My data would support a scenario where B 
cells overexpressing AID may not be allowed to “recycle” into a germinal center for 
proper affinity maturation.  This would require some mechanism for cellular sensing of 
AID expression that would form a feedback loop between proper AID extinction and GC 
cycling.  Particularly if AID forms long-lived complexes on its transcribed DNA 
substrates, one could imagine that funneling of free-floating DNA repair factors onto an 
assembling stable AID mutasome could provide one means of stochiometric “counting” 
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of AID molecules.  Coupling of DNA repair to cell cycle and cell proliferation perhaps 
then informs the choice between continued GC recycling and competition for GC exit.  
Alternatively, thresholds of DNA damage at non-Ig targets of AID mutagenesis could 
serve as proxy read-outs of AID activity.  Perhaps these cycling lymphocytes can only 
tolerate so much collateral damage (whether in the form of generalized DNA damage or 
functional effects specific to mutation of these non-Ig loci) before they are shunted 
towards GC exit.  In either of these scenarios, excess AID activity could overwhelm the 
ability of the system to accurately recognize and release high affinity B lymphocytes.  
This, however, remains pure speculation as little is presently known about the cellular 
and molecular parameters governing the mechanism of proper selection and affinity 
maturation. 
The complex immunodeficiency of the miR-155 deficient mouse highlights the 
immense contribution of miR-155 to various aspects of vertebrate immunity (Rodriguez 
et al., 2007; Thai et al., 2007).  These mice exhibited modest increase in AID expression, 
decreased in vivo CSR to IgG1, and impaired affinity maturation – likely reflecting the 
composite deregulation of at least sixty miR-155-responsive mRNA targets (Vigorito et 
al., 2007a).  In contrast to global ablation of miR-155 regulation, I have described the 
specific disruption of a single miR-155 – s  target interaction.  In our transgenic mouse 
model, I observed robust deregulation of AID-GFP expression, increased in vitro CSR, 
and impaired affinity maturation – some of which may not be apparent in the context of 
total miR-155 deficiency.  Of the deregulated mRNA targets in the miR-155-/- mouse, 
only two have been examined in any detail with respect to miR-155 regulation:  AID, and 
the transcription factor Pu.1 (Vigorito et al., 2007a).  The challenge in coming years will 
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be to validate the entire suite of predicted targets, and integrate this knowledge to 
understand how a single miRNA can coordinate an intricate immune response.   
As a central catalyst for immunoglobulin diversification, AID is regulated by 
networked transcription factors, intracellular trafficking, and protein modifications.  I 
have described an additional miRNA-mediated pathway of AID regulation, which 
controls AID expression in germinal center B cells and ensures proper extinction of AID 
expression as cells affinity mature and exit the secondary lymphoid organs. Thus, miR-
155 plays an important role in the molecular restraint of AID, an enzyme that confers 
great immunological benefit, but must be tightly regulated to limit its mutagenic and 
oncogenic potential.  
The AID miR-155 target site, a relatively miniscule regulatory motif, has been 
evolutionarily maintained amidst a sea of highly divergent 3’UTR sequence – all the way 
from bony fishes to humans.  The conservation of this site almost parallels the 
phylogenetic origins of AID itself, which dates to cartilaginous fishes (Conticello et al., 
2005).  This suggests an ancient, but stringently selected role for miR-155 in regulating 
AID expression.  Recent deep sequencing approaches in simple non-bilaterian animals 
reveal that miRNA function extends deep into animal phylogeny, serving as a primordial 
mechanism of post-transcriptional gene regulation (Grimson et al., 2008).  Conjecturally, 
AID’s first appearance in the evolutionary record was likely followed by the rapid 
acquisition of a regulatory miR-155 target site.  As the immunoglobulin genes co-evolved 
sequence motifs amenable to AID deamination (Jolly et al., 1996; Kepler, 1997; Wagner 
et al., 1995), sequentially giving rise to SHM, then CSR, the reach of miR-155 regulation 
eventually extended to adaptive immunity.   
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Control of miR-155 expression itself is an important factor, given the substantial 
impact of miR-155 function on human health.  Reportedly, AP-1 and NF-κB binding 
sites provide transcriptional control over Bic, but the definitive set of transcriptional 
regulatory factors for the gene is not known (O'Connell et al., 2007; Yin et al., 2008a; 
Yin et al., 2008b).  Bic RNA undergoes co-transcriptional processing (splicing and 
differential polyadenylation), which may also exert as-yet undefined effects on miR-155 
expression (Tam, 2001).  In addition, miR-155 is intriguing from a general perspective of 
miRNA biogenesis, as defects in processing of mature miR-155 from Bic have been 
observed in certain B cell lines (Kluiver et al., 2007).  This may indicate the existence of 
general control mechanisms for miRNA biogenesis that are differentially manipulated in 
healthy and diseased cell states.   
Case-by-case validation of individual miRNA targets, while enormously 
informative, must be supplemented with “big picture” perspectives of miRNA function.  
Bioinformatic approaches have driven, and should continue to drive this outlook on 
miRNA biology, as diverse data sets from target prediction algorithms, miRNA 
expression atlases, and tissue-specific transcriptome or proteome profiles become 
accessible in cross-referenced form.  As a representative example, miR-155 expression is 
relevant to native immune responses, as well as diverse types of cancers (Eis et al., 2005; 
Gironella et al., 2007; Kluiver et al., 2005; van den Berg et al., 2003; Volinia et al., 2006) 
and viral infection (Gottwein et al., 2007; Skalsky et al., 2007).  Comparisons between 
miR-155 specific sets of co-regulated gene could be incredibly useful in understanding 
the expression patterns that determine the balance between healthy and pathological 
function.   
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When the first miRNAs were characterized in nematodes, none could have 
predicted that tiny chains of ribonucleotides could exert such significant influence over 
gene expression throughout evolution and throughout the living world.  We now 
understand that miRNAs establish intricate webs of regulation, where single targets are 
often combinatorially targeted by multiple miRNAs, and conversely, most miRNAs 
regulate multiple targets (Lim et al., 2005).  With the emergence of complex 
physiological systems in higher organisms, ancient mechanisms of miRNA regulation 
have networked with newer mechanisms of transcriptional, post-transcriptional, and post-
translational regulation to create nuanced temporal and spatial patterns of gene 
expression in diverse cell types.  Here I have presented a specific example where one 
miRNA contributes substantially to immunoglobulin gene diversification and adaptive 
immunity.   
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CHAPTER 3:  Noncoding RNAs in cis 
 
 In addition to the undoubtedly extensive network of miRNA control during Ig 
diversification, there are tantalizing hints that long ncRNAs may also influence CSR in 
cis.  As the unrearranged (or germline) constant region genes become activated for DNA 
recombination, they undergo premature noncoding transcription (Fig. 13a).  The sterile 
read-through initiates from the Ig heavy chain enhancer (Eµ) for the Cµ region, or from 
independent promoters located in each of the downstream C regions; then traverses a 
noncoding exon (I), the S region, and the C region exons.  The transcript subsequently 
undergoes splicing to remove the intronic S region and the C region introns.  Site-specific 
germline transcription (GLT) invariably precedes the induction of CSR to a particular 
constant region (Gerondakis, 1990; Lebman et al., 1990; Lutzker and Alt, 1988; Lutzker 
et al., 1988; Radcliffe et al., 1990; Rothman et al., 1990a; Rothman et al., 1990b; 
Stavnezer et al., 1988; Xu and Stavnezer, 1990).  Stop codons litter all three reading 
frames of the I exons, so the transcripts are unlikely to retain any protein-coding capacity.  
Furthermore, B lymphocytes harboring a heterologous sequence in place of the I exon 
can still potentiate CSR (Harriman et al., 1996; Qiu et al., 1999).  However, mutation or 
deletion of the germline promoters leads to CSR defects, indicating that either the process 
of transcription, or the noncoding RNA itself is functionally important (Bottaro et al., 
1998; Jung et al., 1993; Zhang et al., 1993).   
  One aspect of GLT function may relate to creation of accessible single-stranded 
DNA substrates for AID, whether in the context of a transcriptional bubble, or a 
transcription-independent R-loop:  G-rich RNA hybridized to its cognate DNA.  The 
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G/C-rich S regions are supremely amenable to the formation of such structures, and 
indeed, there is some evidence of R-loops arising in mammalian S regions (Daniels and 
Lieber, 1995; Mizuta et al., 2003; Reaban and Griffin, 1990; Reaban et al., 1994; Yu et 
al., 2003).  The G/C-poor S regions of Xenopus, however, are still capable of mediating 
CSR, suggesting that R-loop dependent mechanisms of regulating substrate accessibility 
may have manifested recently in evolution.  Thus, the magnitude of R-loop contribution 
in CSR is uncertain.   It is unknown how an in vivo R-loop at the S region would be 
resolved, and if this model would be consistent with the kinetics of GLT splicing (since 
the S region is excised as an intron, and presumably degraded rapidly).  In addition, the 
C-rich strand of the S region, incapable of forming an R-loop, would require a distinct 
mechanism to generate single-strandedness.   
 Alternate functions for GLT may be proposed based on its known characteristics.  
Given that S region DNA is highly repetitive and palindromic, an RNA transcribed from 
the S region, regardless of transience, would likely harbor secondary structures such as 
double stranded stem-loops.  A possibility I considered was the production of small guide 
RNAs from the pre-spliced GLT.  Conceivably, double stranded RNA motifs could be 
recognized and processed by RNAi machinery to generate sequence specific guides that 
recruit downstream protein effectors for CSR.  As I scanned my small RNA cloning data 
from class switching B lymphocytes, I found no evidence to support this hypothesis (data 
not shown).  I cannot, however, exclude the possibility of S-region derived small RNAs 
outside of the canonical siRNA size range.   
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  To query the general transcriptional accessibility of the unrearranged C regions, I 
assayed for transcripts arising from both strands.  Surprisingly, low abundance antisense 
transcripts accompanied sense GLT, initiating from heterogeneous start sites (Fig. 13b).  
These unpublished observations agree quite well with those reported by Alt and 
colleagues (Perlot et al., 2008).  A similar process of intergenic antisense transcription 
also occurs in the upstream variable regions prior to V(D)J recombination, and has been 
proposed to facilitate DNA recombination by modulating chromatin accessibility 
(Bolland et al., 2004).  Currently, I can only speculate on the functional significance of 
this bidirectional transcription.  The 5’ heterogeneity and the low abundance of the 
antisense transcripts relative to their sense counterparts suggest that:  1) antisense 
transcription depends on prior sense transcription, 2) the antisense transcript may not 
reflect an active promoter-driven process of transcription, 3) the antisense transcript may 
be highly unstable, rapidly degraded, or rapidly processed to disallow accumulation.  One 
can imagine functional scenarios consistent with a transiently available antisense species.  
Rapid annealing of sense and antisense RNA could form a duplex to be processed into 
guide RNAs in an RNAi-independent fashion.  Alternatively, duplexing between the two 
transcripts, followed by degradation could provide a means of regulating sense GLT 
abundance.  This would be important in the case of a quantitative relationship between 
CSR and GLT – which so far, is not clear.  Finally, bidirectional transcription may be 
relevant from the perspective of locus mechanics.  Perhaps convergence of two RNA 
polymerases travelling in opposite directions could create transcriptionally paused S 
region substrates amenable for AID activity.   
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 Clearly, many questions have yet to be resolved on the issue of germline 
transcription, regardless of orientation.  The temporal extent to which this phenomenon 
precedes functional CSR suggests some sort of preparatory significance, perhaps with 
implications for targeting of AID activity or double strand break repair activity.  The role 
of RNA processing, in particular, remains a mystery.  In vivo experiments have 
previously demonstrated that genetic ablation of I exon splice donor sites can severely 
hinder CSR (Hein et al., 1998; Lorenz et al., 1995).  The co-transcriptional processing of 
nascent GLTs – capping, splicing, and polyadenylation – may function outside of direct 
RNA maturation, and instead allow for secondary recruitment of downstream factors.  
For example, the RNA polyadenylation complex has recently been shown to interact with 
DNA repair factors such as Ku70 and DNA-PK, which are key to end joining in CSR 
(Shi et al., 2009).  One could imagine similar role for the spliceosome, an enormous 
multi-protein complex that includes many subunits not directly involved in RNA splicing 
(Zhou et al., 2002).  Thus, early noncoding transcription prior to CSR could pre-assemble 
proteins involved in DNA break repair or end joining at the Ig locus.  Alternatively, the 
GLT itself may potentially attract protein partners independently of co-transcriptional 
RNA processing, acting as a recruitment platform for RNA-binding proteins and 
associated factors that could promote locus accessibility or downstream reactions in CSR.  
Byproducts of splicing could also be functionally important in this context.  Occasional 
examples of highly stable introns have been reported (Clement et al., 2001; Clement et 
al., 1999), so with regard to the Ig locus, a long-lived intronic S region RNA could form a 
highly structured guide RNA, or even support stable R-loop formation at the S region 
DNA.  I am currently investigating several of these testable hypotheses.   
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 In recent years, extended noncoding transcription has been observed on a 
genome-wide scale, with signs of evolutionary conservation (Guttman et al., 2009).  
Computationally, these sites tend to cluster with genes involved in transcriptional 
regulation, and are unlikely to represent transcriptional noise.  Widespread bidirectional 
transcription has also been identified, representing at least two distinct phenomena.  The 
mammalian transcriptome includes copious numbers of coordinated sense and antisense 
transcript pairs (Chen et al., 2004; Katayama et al., 2005; Kiyosawa et al., 2003; Yelin et 
al., 2003), where antisense interference may generally regulate abundance of the sense 
strand.  Recently, a separate observation of diverging bidirectional transcription has been 
made at promoters of active genes (Core et al., 2008; He et al., 2008; Preker et al., 2008; 
Seila et al., 2008; Xu et al., 2009), and is proposed to influence promoter regulation and 
accessibility.  Germline transcription appears to incorporate aspects from each of these 
newly described processes, which may inform our conception of how GLT contributes to 
CSR.  Given the unexpected ubiquity of long ncRNAs in the mammalian transcriptome, I 
expect that GLT may indeed serve as one representative example of how long ncRNAs 
can modulate gene accessibility, targeting, or regulation.  
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CHAPTER 4:  Perspective 
 
Here I have described examples of RNA-mediated regulation of the 
immunoglobulin gene locus – modulated by noncoding RNAs, both large and small.  Far 
from mere relics of an archaic RNA world, regulatory ncRNAs have proven to extend 
RNA function past simple information transfer between DNA and protein.  These RNAs 
show exquisite specificity, as they scan the transcriptome in a sequence-dependent 
manner; as well as functional cooperativity, as they collaborate with RNA-dependent and 
RNA-independent regulatory mechanisms.  One can easily recognize how RNA, as a 
primordial bio-polymer, would embody all the necessary qualities – genetic storage, 
catalytic activity, and regulatory activity – to maintain and propagate organic life in the 
RNA world (Gilbert, 1986; Woese, 1967).   
 These interconnected stories of noncoding RNA regulation in Ig diversification 
testify to a simple truth reiterated endlessly in the scientific literature:  a genome is more 
than the sum of its parts.  As coded information passes linearly from gene to functional 
protein, that information can undergo astonishing amounts of editing – whether in the 
form of somatic DNA alterations (as in Ig diversification), direct regulation by protein 
co-factors (for example, deamination of Ig DNA by AID), direct regulation by noncoding 
RNAs (such as Ig germline transcripts), or secondary regulation (for example, miR-155-
mediated repression of AID).  As these cycles of gene expression and regulation 
propagate in every cell type, in every organism, one can appreciate the awesome 
complexity that has developed through the evolutionary continuum from the very first 
self-replicating biological molecules all the way to sentient life.   
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CHAPTER 5:  Materials and Methods 
 
B lymphocyte isolation and cell culture.  
CD43– naïve splenic B lymphocytes were purified by magnetic separation (MACS, 
Miltenyi Biotec). Cells were maintained at 0.5 - 1 x 106 /ml in standard culture medium, 
and were treated with 5 ng/mL IL-4 (Sigma) and 25 µg/mL LPS (Sigma) to induce CSR 
to IgG1; 25 µg /mL LPS to induce CSR to IgG3; or 25 µg/mL LPS and 0.5 µg/mL IFNγ 
(Sigma) to induce CSR to IgG2a. CH12-F3 cells were maintained in standard culture 
medium, and were treated with 5 ng/mL IL-4, 0.2 µg/mL anti-CD40 (eBioscience), and 
0.1 ng/mL TGF-β (R&D Systems) to induce CSR to IgA. Cell cultures were sampled at 
various time points for FACS analysis or preparation of RNA. 
 
RNA isolation and small RNA cloning.  
Total RNA was prepared with Trizol (Invitrogen), and 21-23 nucleotide RNAs were 
isolated, cloned, sequenced, and catalogued as previously described (Landgraf et al., 
2007).  
 
RNA blots.  
Total RNA (10-20 µg) was run on a 15% TBE-Urea Criterion gel (Bio-rad), and 
transferred to Hybond N+ nylon membrane (Amersham Biosciences) by semi-dry 
blotting. Membranes were UV-crosslinked and dried. A miR-155 probe (5’-
ACCCCTATCACAATTAGCATTAA) was prepared by T4 polynucleotide kinase 
labeling with γ32P-ATP. Blots were hybridized in Denhardt’s solution or QuickHyb 
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(Stratagene) at 50 ºC, and were washed twice with Wash Solution I (5% SDS, 5x SSC), 
and twice with Wash Solution II (1% SDS, 1x SSC). 
 
Luciferase assays.  
Reporter constructs were modified from the pRL-TK plasmid (Promega). The renilla 
luciferase gene was replaced by firefly luciferase (fLuc) to create the Luc construct. The 
3’UTR of the AID mRNA was cloned directly downstream of fLuc to create the Luc-
UTR plasmid. This was then altered by Quikchange PCR (Stratagene) to create the Luc-
UTR-Del and Luc-UTR Mut constructs. CH12-F3 cells were co-transfected with a 
reporter construct and pRL-TK by Amaxa nucleofection, and were stimulated for CSR as 
above. Cells were lysed 48 hours after transfection and the Dual Luciferase Reporter 
Assay System (Promega) was used to measure firefly and renilla luciferase activities. 
 
CSR rescue by AID-GFP.  
Replication-deficient retroviruses were generated by transfection of 293T cells with 
either AID-GFP-pQCXIP or pQCXIP alone, along with pCL-Eco packaging plasmid. 
Viral stocks were used to transduce naïve splenic B lymphocytes from AID-/- mice, which 
had been stimulated in culture with IL-4 and LPS. 
 
Transgenic mice.  
The AID-GFP-Mut BAC was modified from the AID-GFP BAC used to create the 
previously described AID-GFP reporter mouse (Crouch et al., 2007) (copy number 
ranging from 1-10). Mutation of the miR-155 target site was achieved by homologous 
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recombination in bacteria as described previously (Misulovin et al., 2001). Briefly, the 
AID miR-155 target site plus ~1 kb flanking sequence on either side (for homologous 
recombination) was amplified by PCR from BAC RP24-68I7 (Genbank AC158651) 
using the following primers:  5'-GGCGCGCCGGTAAGTCTGCCTGTCTGTCTGCC 
and 5'-GCGGCCGCGCGTCATTTCCTTGCCACGG.  The PCR product was cloned into 
TOPO-pCR4 (Invitrogen). Point mutations in the miR-155 target site were introduced by 
Quikchange PCR (Stratagene).  The sequence was again amplified with the same primers 
as above, and cloned into shuttle vector pLD53.SC.AEB (which also contains the RecA 
and SacB genes).  After propagation in PIR2 bacteria (Invitrogen), the construct was 
electroporated into bacteria carrying the previously-described modified BAC RP24-68I7 
containing the AID-GFP locus (Crouch et al., 2007).  Cointegrates were selected for in 
liquid culture in the presence of ampicillin (for the insert-containing shuttle vector) and 
chloramphenicol (for the BAC), during which RecA-mediated recombination occurred 
between the BAC and homologous sequences inserted into the shuttle vector.  Cultures 
were plated on chloramphenicol, and the desired recombination event (introduction of the 
modified miR-155 target site into BAC and deletion of the shuttle vector sequence) was 
ensured by treating duplicate plates with UV illumination and sucrose to ensure the loss 
of the shuttle-vector-encoded RecA and SacB, respectively.  Integrity of the newly-
generated AID-GFP-Mut locus was confirmed by sequencing.  Generation of the AID-
GFP-Mut transgenic founder mice (copy number ranging from 5-20) was performed by 
the Rockefeller University Transgenic Services Laboratory, using standard methods.  
Transgene copy numbers were estimated by comparison to copy number standards in 
Southern analysis.  Animals were housed and studied in accordance with institutional 
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guidelines. 
 
Quantitative PCR. 
cDNA was generated from DNAse-I-treated RNA, and AID-GFP expression was 
monitored by quantitative PCR (5’- GACTTGCGAGATGCATTTCGTATG and 5’- 
GCTGAACTTGTGGCCGTTTAC).  cDNA samples were normalized by also amplifying 
Ku70 (5’- TGCCCTTTACTGAGAAGGTGAC and 5’- 
TGCTGCAGGACTGGATTCTC).   
 
Immunization and ELISA.  
Mice were immunized with 100 µg alum-precipitated NP-CGG (Biosearch Technologies) 
by intraperitoneal injection. Serum was prepared from peripheral blood collected by 
retro-orbital bleed at various time points. Serum dilutions were incubated in NP3-BSA or 
NP30-BSA -coated wells of microtiter plates, and NP-specific Ig were detected by ELISA 
using reagents from Southern Biotechnologies Clonotyping System-HRP. Affinity 
maturation was calculated as the ratio of NP3-binding (high affinity anti-NP Ig) to NP30-
binding (total anti-NP Ig). 
 
FACS analysis.  
Cell suspensions from bone marrow, spleen, Peyer’s patches, thymus, and peripheral 
blood were prepared and stained for FACS using standard procedures. The following 
reagents were used to stain cells for FACS analysis (all are from BD Biosciences except 
where indicated): CD93-PE (eBioscience), IgM-APC (Jackson Immunoresearch), CD95-
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PE-Cy7, B220-PerCP, B220-APC, IgG1-biotin, IgM-biotin, IgD-biotin (eBioscience), 
CD8-PerCP, CD4-APC, NP-PE (Biosearch Technologies), Streptavidin-PerCP. 
 
Mutational analysis.  
Genomic DNA was prepared from sorted splenic germinal center B cells and white blood 
cells from peripheral blood. The following were PCR-amplified with PfuTURBO 
polymerase (Stratagene): JH4 intron (5'-AGCCTGACATCTGAGGAC and 5'-
TAGTGTGGAACATTCCTCAC, annealing temperature 55 ºC for 35 cycles; followed 
by a nested reaction 5'-CTGACATCTGAGGACTCTGC and 5'-
GCTGTCACAGAGGTGGTCCTG, annealing temperature 58 ºC for 35 cycles);  
VH186.2 (5'- TCTTTACAGTTACTGAGCACACAGGAC and 5'- 
GGGTCTAGAGGTGTCCCTAGTCCTTCATGACC, annealing temperature 50 ºC for 
35 cycles; followed by a nested reaction 5'-CAGTAGCAGGCTTGAGGTCTGGAC and 
5'- GGGTCTAGAGGTGTCCCTAGTCCTTCATGACC, annealing temperature 64 ºC 
for 35 cycles); bcl-6 (5'-GGCCGGACACCAGGTGATTAT and 5'- 
AGGGAGGGAACTACCGCTGAG, annealing temperature 68 ºC for 35 cycles).  
PCR products were blunt-end cloned into pSC-B (Stratagene), and sequenced using a 
standard T3 primer. 
 
Strand-Specific RT-PCR. 
Total RNA was prepared from splenic B cells using Trizol (Invitrogen) and treated with 
DNAse I (Promega).  The One-Step RT-PCR kit (Qiagen) was used to assay for strand 
specific transcripts, where only one primer was added to the reverse transcription 
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reaction, followed by addition of the second primer for the PCR amplification rounds.  
The primers used were:  µ1F – 5’-GCATTTACAGTGACTTTGTTCATG, µ1R – 5’-
CAGCAGCCTGGTCTCAGAC, µ4F – 5’-GGAACAAGGTTGAGAGCCC, µ4R – 5’-
CAGCTCACCCCAACACAGC, µ6F – 5’-GGCTGGGTGAGCTGGAG, µ6R – 5’-
GCTCAGCCCCGTTCATTC, µ8F – 5’-CAGTCCTTCCCAAATGTCTTC, µ8R – 5’-
GGTATTCATCTGAACCTTCAAG; γ1F – 5’-CTGCTTTCACAGCTTCCACATG, γ1R 
– 5’-CCATGCCAAACACATTCCTCAG, γ4F – 5’-CCACTCTTCCATTTGTCCTTG, 
γ4R – 5’-GGAGACCAGGCTGAGCAG, γ5F – 5’-CTGCGTCTATTCAGCCTTGAC, 
γ5R – 5’-GCCTTGGGAGCCAGAACAG, γ8F – 5’-CCAAACTAACTCCATGGTGAC, 
γ8R – 5’-GTCCACCTTGGTGCTGCTG. 
 
5’ RACE PCR. 
5’-end mapping of antisense transcripts was carried out using a 5’RACE PCR kit 
(Invitrogen), using primers listed above, and the following additional primers:  µ1Fn – 
5’-GCCTTACTATTAAGACTTTGACATT, µ4Fn – 5’-
GCGAGGCTCTAAAAAGCAT, µ6Fn – 5’-GAGCTGAGCTGAGGTGAAC, µ8Fn – 
5’-CCCCTGTCTGATAAGAATCTG; γ2Fn – 5’-CCTGAGCCCCGAGGATATC, γ5Fn 
– 5’-CCAAGGGATAGACATGTAAGC, γ8Fn – 5’-CCTGGGATGCCTGGTCAAG.   
 
74 
REFERENCES 
 
Akira, S., Okazaki, K., and Sakano, H. (1987). Two pairs of recombination signals are 
sufficient to cause immunoglobulin V-(D)-J joining. Science 238, 1134-1138. 
Aoufouchi, S., Faili, A., Zober, C., D'Orlando, O., Weller, S., Weill, J.C., and Reynaud, 
C.A. (2008). Proteasomal degradation restricts the nuclear lifespan of AID. J Exp Med 
205, 1357-1368. 
Arakawa, H., Hauschild, J., and Buerstedde, J.M. (2002). Requirement of the activation-
induced deaminase (AID) gene for immunoglobulin gene conversion. Science 295, 1301-
1306. 
Aravin, A.A., Sachidanandam, R., Bourc'his, D., Schaefer, C., Pezic, D., Toth, K.F., 
Bestor, T., and Hannon, G.J. (2008). A piRNA pathway primed by individual transposons 
is linked to de novo DNA methylation in mice. Mol Cell 31, 785-799. 
Aravin, A.A., Sachidanandam, R., Girard, A., Fejes-Toth, K., and Hannon, G.J. (2007). 
Developmentally regulated piRNA clusters implicate MILI in transposon control. Science 
316, 744-747. 
Avery, O.T., MacLeod, C.M., and McCarty, M. (1944). Studies on the chemical nature of 
the substance inducing transformation of pneumococcal types. J Exp Med 79, 137-159. 
Axtell, M.J., and Bowman, J.L. (2008). Evolution of plant microRNAs and their targets. 
Trends Plant Sci 13, 343-349. 
Bachl, J., Carlson, C., Gray-Schopfer, V., Dessing, M., and Olsson, C. (2001). Increased 
transcription levels induce higher mutation rates in a hypermutating cell line. J Immunol 
166, 5051-5057. 
Bachl, J., Ertongur, I., and Jungnickel, B. (2006). Involvement of Rad18 in somatic 
hypermutation. Proc Natl Acad Sci U S A 103, 12081-12086. 
Bao, N., Lye, K.W., and Barton, M.K. (2004). MicroRNA binding sites in Arabidopsis 
class III HD-ZIP mRNAs are required for methylation of the template chromosome. Dev 
Cell 7, 653-662. 
Bardwell, P.D., Woo, C.J., Wei, K., Li, Z., Martin, A., Sack, S.Z., Parris, T., Edelmann, 
W., and Scharff, M.D. (2004). Altered somatic hypermutation and reduced class-switch 
recombination in exonuclease 1-mutant mice. Nat Immunol 5, 224-229. 
Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 
116, 281-297. 
75 
Bartolomei, M.S., Zemel, S., and Tilghman, S.M. (1991). Parental imprinting of the 
mouse H19 gene. Nature 351, 153-155. 
Basu, U., Chaudhuri, J., Alpert, C., Dutt, S., Ranganath, S., Li, G., Schrum, J.P., Manis, 
J.P., and Alt, F.W. (2005). The AID antibody diversification enzyme is regulated by 
protein kinase A phosphorylation. Nature 438, 508-511. 
Basu, U., Chaudhuri, J., Phan, R.T., Datta, A., and Alt, F.W. (2007). Regulation of 
activation induced deaminase via phosphorylation. Adv Exp Med Biol 596, 129-137. 
Basu, U., Wang, Y., and Alt, F.W. (2008). Evolution of phosphorylation-dependent 
regulation of activation-induced cytidine deaminase. Mol Cell 32, 285-291. 
Becker, R.S., and Knight, K.L. (1990). Somatic diversification of immunoglobulin heavy 
chain VDJ genes: evidence for somatic gene conversion in rabbits. Cell 63, 987-997. 
Beltran, M., Puig, I., Pena, C., Garcia, J.M., Alvarez, A.B., Pena, R., Bonilla, F., and de 
Herreros, A.G. (2008). A natural antisense transcript regulates Zeb2/Sip1 gene expression 
during Snail1-induced epithelial-mesenchymal transition. Genes Dev 22, 756-769. 
Bernstein, E., Caudy, A.A., Hammond, S.M., and Hannon, G.J. (2001). Role for a 
bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366. 
Berretta, J., Pinskaya, M., and Morillon, A. (2008). A cryptic unstable transcript mediates 
transcriptional trans-silencing of the Ty1 retrotransposon in S. cerevisiae. Genes Dev 22, 
615-626. 
Berton, M.T., Uhr, J.W., and Vitetta, E.S. (1989). Synthesis of germ-line gamma 1 
immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and 
inhibition by interferon gamma. Proc Natl Acad Sci U S A 86, 2829-2833. 
Bird, A.J., Gordon, M., Eide, D.J., and Winge, D.R. (2006). Repression of ADH1 and 
ADH3 during zinc deficiency by Zap1-induced intergenic RNA transcripts. Embo J 25, 
5726-5734. 
Birney, E., Stamatoyannopoulos, J.A., Dutta, A., Guigo, R., Gingeras, T.R., Margulies, 
E.H., Weng, Z., Snyder, M., Dermitzakis, E.T., Thurman, R.E., et al. (2007). 
Identification and analysis of functional elements in 1% of the human genome by the 
ENCODE pilot project. Nature 447, 799-816. 
Black, D.L., Chabot, B., and Steitz, J.A. (1985). U2 as well as U1 small nuclear 
ribonucleoproteins are involved in premessenger RNA splicing. Cell 42, 737-750. 
Bolland, D.J., Wood, A.L., Johnston, C.M., Bunting, S.F., Morgan, G., Chakalova, L., 
Fraser, P.J., and Corcoran, A.E. (2004). Antisense intergenic transcription in V(D)J 
recombination. Nat Immunol 5, 630-637. 
76 
Borsani, G., Tonlorenzi, R., Simmler, M.C., Dandolo, L., Arnaud, D., Capra, V., 
Grompe, M., Pizzuti, A., Muzny, D., Lawrence, C., et al. (1991). Characterization of a 
murine gene expressed from the inactive X chromosome. Nature 351, 325-329. 
Bottaro, A., Young, F., Chen, J., Serwe, M., Sablitzky, F., and Alt, F.W. (1998). Deletion 
of the IgH intronic enhancer and associated matrix-attachment regions decreases, but 
does not abolish, class switching at the mu locus. Int Immunol 10, 799-806. 
Bringmann, P., Appel, B., Rinke, J., Reuter, R., Theissen, H., and Luhrmann, R. (1984). 
Evidence for the existence of snRNAs U4 and U6 in a single ribonucleoprotein complex 
and for their association by intermolecular base pairing. Embo J 3, 1357-1363. 
Brown, C.J., Ballabio, A., Rupert, J.L., Lafreniere, R.G., Grompe, M., Tonlorenzi, R., 
and Willard, H.F. (1991). A gene from the region of the human X inactivation centre is 
expressed exclusively from the inactive X chromosome. Nature 349, 38-44. 
Burnet, F.M. (1957). A modification of Jerne's theory of antibody production usign the 
concept of clonal selection. Aust J Sci 20, 67-69. 
Camblong, J., Iglesias, N., Fickentscher, C., Dieppois, G., and Stutz, F. (2007). Antisense 
RNA stabilization induces transcriptional gene silencing via histone deacetylation in S. 
cerevisiae. Cell 131, 706-717. 
Carlson, L.M., McCormack, W.T., Postema, C.E., Humphries, E.H., and Thompson, C.B. 
(1990). Templated insertions in the rearranged chicken IgL V gene segment arise by 
intrachromosomal gene conversion. Genes Dev 4, 536-547. 
Casellas, R., Nussenzweig, A., Wuerffel, R., Pelanda, R., Reichlin, A., Suh, H., Qin, 
X.F., Besmer, E., Kenter, A., Rajewsky, K., et al. (1998). Ku80 is required for 
immunoglobulin isotype switching. Embo J 17, 2404-2411. 
Chabot, B., Black, D.L., LeMaster, D.M., and Steitz, J.A. (1985). The 3' splice site of 
pre-messenger RNA is recognized by a small nuclear ribonucleoprotein. Science 230, 
1344-1349. 
Chaudhuri, J., Khuong, C., and Alt, F.W. (2004). Replication protein A interacts with 
AID to promote deamination of somatic hypermutation targets. Nature 430, 992-998. 
Chen, J., Sun, M., Kent, W.J., Huang, X., Xie, H., Wang, W., Zhou, G., Shi, R.Z., and 
Rowley, J.D. (2004). Over 20% of human transcripts might form sense-antisense pairs. 
Nucleic Acids Res 32, 4812-4820. 
Chien, Y.H., Gascoigne, N.R., Kavaler, J., Lee, N.E., and Davis, M.M. (1984). Somatic 
recombination in a murine T-cell receptor gene. Nature 309, 322-326. 
Chowdhury, M., Forouhi, O., Dayal, S., McCloskey, N., Gould, H.J., Felsenfeld, G., and 
Fear, D.J. (2008). Analysis of intergenic transcription and histone modification across the 
human immunoglobulin heavy-chain locus. Proc Natl Acad Sci U S A 105, 15872-15877. 
77 
Clement, J.Q., Maiti, S., and Wilkinson, M.F. (2001). Localization and stability of introns 
spliced from the Pem homeobox gene. J Biol Chem 276, 16919-16930. 
Clement, J.Q., Qian, L., Kaplinsky, N., and Wilkinson, M.F. (1999). The stability and 
fate of a spliced intron from vertebrate cells. Rna 5, 206-220. 
Clurman, B.E., and Hayward, W.S. (1989). Multiple proto-oncogene activations in avian 
leukosis virus-induced lymphomas: evidence for stage-specific events. Mol Cell Biol 9, 
2657-2664. 
Conticello, S.G., Ganesh, K., Xue, K., Lu, M., Rada, C., and Neuberger, M.S. (2008). 
Interaction between antibody-diversification enzyme AID and spliceosome-associated 
factor CTNNBL1. Mol Cell 31, 474-484. 
Conticello, S.G., Thomas, C.J., Petersen-Mahrt, S.K., and Neuberger, M.S. (2005). 
Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. 
Mol Biol Evol 22, 367-377. 
Core, L.J., Waterfall, J.J., and Lis, J.T. (2008). Nascent RNA sequencing reveals 
widespread pausing and divergent initiation at human promoters. Science 322, 1845-
1848. 
Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N., and Croce, 
C.M. (2006). Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma 
in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 103, 7024-7029. 
Crick, F.H.C. (1958). On protein synthesis. Symp Soc Exp Biol 12, 138-163. 
Crick, F.H.C. (1970). Central dogma of molecular biology. Nature 227, 561-563. 
Crouch, E.E., Li, Z., Takizawa, M., Fichtner-Feigl, S., Gourzi, P., Montano, C., 
Feigenbaum, L., Wilson, P., Janz, S., Papavasiliou, F.N., et al. (2007). Regulation of AID 
expression in the immune response. J Exp Med 204, 1145-1156. 
Cumano, A., and Rajewsky, K. (1985). Structure of primary anti-(4-hydroxy-3-
nitrophenyl)acetyl (NP) antibodies in normal and idiotypically suppressed C57BL/6 
mice. Eur J Immunol 15, 512-520. 
Daniels, G.A., and Lieber, M.R. (1995). RNA:DNA complex formation upon 
transcription of immunoglobulin switch regions: implications for the mechanism and 
regulation of class switch recombination. Nucleic Acids Res 23, 5006-5011. 
Dedeoglu, F., Horwitz, B., Chaudhuri, J., Alt, F.W., and Geha, R.S. (2004). Induction of 
activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is 
dependent on STAT6 and NFkappaB. Int Immunol 16, 395-404. 
78 
Delbos, F., Aoufouchi, S., Faili, A., Weill, J.C., and Reynaud, C.A. (2007). DNA 
polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene 
hypermutation in the mouse. J Exp Med 204, 17-23. 
Delbos, F., De Smet, A., Faili, A., Aoufouchi, S., Weill, J.C., and Reynaud, C.A. (2005). 
Contribution of DNA polymerase eta to immunoglobulin gene hypermutation in the 
mouse. J Exp Med 201, 1191-1196. 
Di Noia, J., and Neuberger, M.S. (2002). Altering the pathway of immunoglobulin 
hypermutation by inhibiting uracil-DNA glycosylase. Nature 419, 43-48. 
Difilippantonio, S., Celeste, A., Fernandez-Capetillo, O., Chen, H.T., Reina San Martin, 
B., Van Laethem, F., Yang, Y.P., Petukhova, G.V., Eckhaus, M., Feigenbaum, L., et al. 
(2005). Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse 
models. Nat Cell Biol 7, 675-685. 
Ding, S.W., and Voinnet, O. (2007). Antiviral immunity directed by small RNAs. Cell 
130, 413-426. 
Dorsett, Y., McBride, K.M., Jankovic, M., Gazumyan, A., Thai, T.H., Robbiani, D.F., Di 
Virgilio, M., San-Martin, B.R., Heidkamp, G., Schwickert, T.A., et al. (2008). 
MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh 
translocation. Immunity 28, 630-638. 
Early, P., Huang, H., Davis, M., Calame, K., and Hood, L. (1980). An immunoglobulin 
heavy chain variable region gene is generated from three segments of DNA: VH, D and 
JH. Cell 19, 981-992. 
Early, P.W., Davis, M.M., Kaback, D.B., Davidson, N., and Hood, L. (1979). 
Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic 
clone containing variable and alpha constant regions. Proc Natl Acad Sci U S A 76, 857-
861. 
Ehrenstein, M.R., and Neuberger, M.S. (1999). Deficiency in Msh2 affects the efficiency 
and local sequence specificity of immunoglobulin class-switch recombination: parallels 
with somatic hypermutation. Embo J 18, 3484-3490. 
Ehrenstein, M.R., Rada, C., Jones, A.M., Milstein, C., and Neuberger, M.S. (2001). 
Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated 
mechanism of Ig class switch recombination. Proc Natl Acad Sci U S A 98, 14553-
14558. 
Eis, P.S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M.F., Lund, E., and Dahlberg, 
J.E. (2005). Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc 
Natl Acad Sci U S A 102, 3627-3632. 
Endo, Y., Marusawa, H., Kou, T., Nakase, H., Fujii, S., Fujimori, T., Kinoshita, K., 
Honjo, T., and Chiba, T. (2008). Activation-induced cytidine deaminase links between 
79 
inflammation and the development of colitis-associated colorectal cancers. 
Gastroenterology 135, 889-898, 898 e881-883. 
Epshtein, V., Mironov, A.S., and Nudler, E. (2003). The riboswitch-mediated control of 
sulfur metabolism in bacteria. Proc Natl Acad Sci U S A 100, 5052-5056. 
Espinoza, C.A., Allen, T.A., Hieb, A.R., Kugel, J.F., and Goodrich, J.A. (2004). B2 RNA 
binds directly to RNA polymerase II to repress transcript synthesis. Nat Struct Mol Biol 
11, 822-829. 
Esser, C., and Radbruch, A. (1989). Rapid induction of transcription of unrearranged S 
gamma 1 switch regions in activated murine B cells by interleukin 4. Embo J 8, 483-488. 
Feng, J., Bi, C., Clark, B.S., Mady, R., Shah, P., and Kohtz, J.D. (2006). The Evf-2 
noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a 
Dlx-2 transcriptional coactivator. Genes Dev 20, 1470-1484. 
Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., and Mello, C.C. (1998). 
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis 
elegans. Nature 391, 806-811. 
Forster, A.C., and Symons, R.H. (1987a). Self-cleavage of plus and minus RNAs of a 
virusoid and a structural model for the active sites. Cell 49, 211-220. 
Forster, A.C., and Symons, R.H. (1987b). Self-cleavage of virusoid RNA is performed by 
the proposed 55-nucleotide active site. Cell 50, 9-16. 
Franklin, R.E., and Gosling, R.G. (1953). Molecular configuration in sodium 
thymonucleate. Nature 171, 740-741. 
Fukita, Y., Jacobs, H., and Rajewsky, K. (1998). Somatic hypermutation in the heavy 
chain locus correlates with transcription. Immunity 9, 105-114. 
Furukawa, K., Akasako-Furukawa, A., Shirai, H., Nakamura, H., and Azuma, T. (1999). 
Junctional amino acids determine the maturation pathway of an antibody. Immunity 11, 
329-338. 
Ganot, P., Bortolin, M.L., and Kiss, T. (1997). Site-specific pseudouridine formation in 
preribosomal RNA is guided by small nucleolar RNAs. Cell 89, 799-809. 
Ganot, P., Jady, B.E., Bortolin, M.L., Darzacq, X., and Kiss, T. (1999). Nucleolar factors 
direct the 2'-O-ribose methylation and pseudouridylation of U6 spliceosomal RNA. Mol 
Cell Biol 19, 6906-6917. 
Gao, Y., Chaudhuri, J., Zhu, C., Davidson, L., Weaver, D.T., and Alt, F.W. (1998). A 
targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in 
V(D)J recombination. Immunity 9, 367-376. 
80 
Gendrel, A.V., Lippman, Z., Yordan, C., Colot, V., and Martienssen, R.A. (2002). 
Dependence of heterochromatic histone H3 methylation patterns on the Arabidopsis gene 
DDM1. Science 297, 1871-1873. 
Gerondakis, S. (1990). Structure and expression of murine germ-line immunoglobulin 
epsilon heavy chain transcripts induced by interleukin 4. Proc Natl Acad Sci U S A 87, 
1581-1585. 
Gilbert, W. (1986). The RNA world. Nature 319, 618. 
Gironella, M., Seux, M., Xie, M.J., Cano, C., Tomasini, R., Gommeaux, J., Garcia, S., 
Nowak, J., Yeung, M.L., Jeang, K.T., et al. (2007). Tumor protein 53-induced nuclear 
protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic 
tumor development. Proc Natl Acad Sci U S A 104, 16170-16175. 
Golding, G.B., Gearhart, P.J., and Glickman, B.W. (1987). Patterns of somatic mutations 
in immunoglobulin variable genes. Genetics 115, 169-176. 
Gonda, H., Sugai, M., Nambu, Y., Katakai, T., Agata, Y., Mori, K.J., Yokota, Y., and 
Shimizu, A. (2003). The balance between Pax5 and Id2 activities is the key to AID gene 
expression. J Exp Med 198, 1427-1437. 
Gong, S., Zheng, C., Doughty, M.L., Losos, K., Didkovsky, N., Schambra, U.B., Nowak, 
N.J., Joyner, A., Leblanc, G., Hatten, M.E., et al. (2003). A gene expression atlas of the 
central nervous system based on bacterial artificial chromosomes. Nature 425, 917-925. 
Gottwein, E., Mukherjee, N., Sachse, C., Frenzel, C., Majoros, W.H., Chi, J.T., Braich, 
R., Manoharan, M., Soutschek, J., Ohler, U., et al. (2007). A viral microRNA functions 
as an orthologue of cellular miR-155. Nature 450, 1096-1099. 
Grawunder, U., Leu, T.M., Schatz, D.G., Werner, A., Rolink, A.G., Melchers, F., and 
Winkler, T.H. (1995). Down-regulation of RAG1 and RAG2 gene expression in preB 
cells after functional immunoglobulin heavy chain rearrangement. Immunity 3, 601-608. 
Grawunder, U., Zimmer, D., Fugmann, S., Schwarz, K., and Lieber, M.R. (1998). DNA 
ligase IV is essential for V(D)J recombination and DNA double-strand break repair in 
human precursor lymphocytes. Mol Cell 2, 477-484. 
Gribnau, J., Diderich, K., Pruzina, S., Calzolari, R., and Fraser, P. (2000). Intergenic 
transcription and developmental remodeling of chromatin subdomains in the human beta-
globin locus. Mol Cell 5, 377-386. 
Griffiths-Jones, S., Grocock, R.J., van Dongen, S., Bateman, A., and Enright, A.J. (2006). 
miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34, 
D140-144. 
Griffiths-Jones, S., Saini, H.K., van Dongen, S., and Enright, A.J. (2008). miRBase: tools 
for microRNA genomics. Nucleic Acids Res 36, D154-158. 
81 
Grimson, A., Farh, K.K., Johnston, W.K., Garrett-Engele, P., Lim, L.P., and Bartel, D.P. 
(2007). MicroRNA targeting specificity in mammals: determinants beyond seed pairing. 
Mol Cell 27, 91-105. 
Grimson, A., Srivastava, M., Fahey, B., Woodcroft, B.J., Chiang, H.R., King, N., 
Degnan, B.M., Rokhsar, D.S., and Bartel, D.P. (2008). Early origins and evolution of 
microRNAs and Piwi-interacting RNAs in animals. Nature 455, 1193-1197. 
Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N., and Altman, S. (1983). The RNA 
moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857. 
Guikema, J.E., Linehan, E.K., Tsuchimoto, D., Nakabeppu, Y., Strauss, P.R., Stavnezer, 
J., and Schrader, C.E. (2007). APE1- and APE2-dependent DNA breaks in 
immunoglobulin class switch recombination. J Exp Med 204, 3017-3026. 
Guo, S., and Kemphues, K.J. (1995). par-1, a gene required for establishing polarity in C. 
elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. 
Cell 81, 611-620. 
Guttman, M., Amit, I., Garber, M., French, C., Lin, M.F., Feldser, D., Huarte, M., Zuk, 
O., Carey, B.W., Cassady, J.P., et al. (2009). Chromatin signature reveals over a 
thousand highly conserved large non-coding RNAs in mammals. Nature. 
Haasch, D., Chen, Y.W., Reilly, R.M., Chiou, X.G., Koterski, S., Smith, M.L., Kroeger, 
P., McWeeny, K., Halbert, D.N., Mollison, K.W., et al. (2002). T cell activation induces 
a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and 
encoded by the proto-oncogene, BIC. Cell Immunol 217, 78-86. 
Hamilton, A.J., and Baulcombe, D.C. (1999). A species of small antisense RNA in 
posttranscriptional gene silencing in plants. Science 286, 950-952. 
Hammond, S.M., Bernstein, E., Beach, D., and Hannon, G.J. (2000). An RNA-directed 
nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404, 
293-296. 
Hammond, S.M., Boettcher, S., Caudy, A.A., Kobayashi, R., and Hannon, G.J. (2001). 
Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293, 
1146-1150. 
Han, L., and Yu, K. (2008). Altered kinetics of nonhomologous end joining and class 
switch recombination in ligase IV--deficient B cells. J Exp Med 205, 2745-2753. 
Harriman, G.R., Bradley, A., Das, S., Rogers-Fani, P., and Davis, A.C. (1996). IgA class 
switch in I alpha exon-deficient mice. Role of germline transcription in class switch 
recombination. J Clin Invest 97, 477-485. 
Hartig, J.V., Tomari, Y., and Forstemann, K. (2007). piRNAs--the ancient hunters of 
genome invaders. Genes Dev 21, 1707-1713. 
82 
Hatten, M.E., and Heintz, N. (2005). Large-scale genomic approaches to brain 
development and circuitry. Annu Rev Neurosci 28, 89-108. 
He, Y., Vogelstein, B., Velculescu, V.E., Papadopoulos, N., and Kinzler, K.W. (2008). 
The antisense transcriptomes of human cells. Science 322, 1855-1857. 
Hein, K., Lorenz, M.G., Siebenkotten, G., Petry, K., Christine, R., and Radbruch, A. 
(1998). Processing of switch transcripts is required for targeting of antibody class switch 
recombination. J Exp Med 188, 2369-2374. 
Henderson, I.R., Zhang, X., Lu, C., Johnson, L., Meyers, B.C., Green, P.J., and Jacobsen, 
S.E. (2006). Dissecting Arabidopsis thaliana DICER function in small RNA processing, 
gene silencing and DNA methylation patterning. Nat Genet 38, 721-725. 
Hershey, A.D., and Chase, M. (1952). Independent functions of viral protein and nucleic 
acid in growth of bacteriophage. J Gen Physiol 36, 39-56. 
Hirota, K., Miyoshi, T., Kugou, K., Hoffman, C.S., Shibata, T., and Ohta, K. (2008). 
Stepwise chromatin remodelling by a cascade of transcription initiation of non-coding 
RNAs. Nature 456, 130-134. 
Hongay, C.F., Grisafi, P.L., Galitski, T., and Fink, G.R. (2006). Antisense transcription 
controls cell fate in Saccharomyces cerevisiae. Cell 127, 735-745. 
Houwing, S., Kamminga, L.M., Berezikov, E., Cronembold, D., Girard, A., van den Elst, 
H., Filippov, D.V., Blaser, H., Raz, E., Moens, C.B., et al. (2007). A role for Piwi and 
piRNAs in germ cell maintenance and transposon silencing in Zebrafish. Cell 129, 69-82. 
Hutvagner, G., McLachlan, J., Pasquinelli, A.E., Balint, E., Tuschl, T., and Zamore, P.D. 
(2001). A cellular function for the RNA-interference enzyme Dicer in the maturation of 
the let-7 small temporal RNA. Science 293, 834-838. 
Hutvagner, G., and Zamore, P.D. (2002). A microRNA in a multiple-turnover RNAi 
enzyme complex. Science 297, 2056-2060. 
Ilik, I., and Akhtar, A. (2009). roX RNAs: Non-coding regulators of the male X 
chromosome in flies. RNA Biol 6. 
Imai, K., Slupphaug, G., Lee, W.I., Revy, P., Nonoyama, S., Catalan, N., Yel, L., 
Forveille, M., Kavli, B., Krokan, H.E., et al. (2003). Human uracil-DNA glycosylase 
deficiency associated with profoundly impaired immunoglobulin class-switch 
recombination. Nat Immunol 4, 1023-1028. 
Ito, S., Nagaoka, H., Shinkura, R., Begum, N., Muramatsu, M., Nakata, M., and Honjo, 
T. (2004). Activation-induced cytidine deaminase shuttles between nucleus and 
cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc Natl Acad 
Sci U S A 101, 1975-1980. 
83 
Jady, B.E., and Kiss, T. (2001). A small nucleolar guide RNA functions both in 2'-O-
ribose methylation and pseudouridylation of the U5 spliceosomal RNA. Embo J 20, 541-
551. 
Jansen, J.G., Langerak, P., Tsaalbi-Shtylik, A., van den Berk, P., Jacobs, H., and de 
Wind, N. (2006). Strand-biased defect in C/G transversions in hypermutating 
immunoglobulin genes in Rev1-deficient mice. J Exp Med 203, 319-323. 
John, B., Enright, A.J., Aravin, A., Tuschl, T., Sander, C., and Marks, D.S. (2004). 
Human MicroRNA targets. PLoS Biol 2, e363. 
Jolly, C.J., Wagner, S.D., Rada, C., Klix, N., Milstein, C., and Neuberger, M.S. (1996). 
The targeting of somatic hypermutation. Semin Immunol 8, 159-168. 
Jung, S., Rajewsky, K., and Radbruch, A. (1993). Shutdown of class switch 
recombination by deletion of a switch region control element. Science 259, 984-987. 
Kapranov, P., Cheng, J., Dike, S., Nix, D.A., Duttagupta, R., Willingham, A.T., Stadler, 
P.F., Hertel, J., Hackermuller, J., Hofacker, I.L., et al. (2007). RNA maps reveal new 
RNA classes and a possible function for pervasive transcription. Science 316, 1484-1488. 
Katayama, S., Tomaru, Y., Kasukawa, T., Waki, K., Nakanishi, M., Nakamura, M., 
Nishida, H., Yap, C.C., Suzuki, M., Kawai, J., et al. (2005). Antisense transcription in the 
mammalian transcriptome. Science 309, 1564-1566. 
Kavaler, J., Davis, M.M., and Chien, Y. (1984). Localization of a T-cell receptor 
diversity-region element. Nature 310, 421-423. 
Kavli, B., Andersen, S., Otterlei, M., Liabakk, N.B., Imai, K., Fischer, A., Durandy, A., 
Krokan, H.E., and Slupphaug, G. (2005). B cells from hyper-IgM patients carrying UNG 
mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil. J 
Exp Med 201, 2011-2021. 
Kepler, T.B. (1997). Codon bias and plasticity in immunoglobulins. Mol Biol Evol 14, 
637-643. 
Kettenberger, H., Eisenfuhr, A., Brueckner, F., Theis, M., Famulok, M., and Cramer, P. 
(2006). Structure of an RNA polymerase II-RNA inhibitor complex elucidates 
transcription regulation by noncoding RNAs. Nat Struct Mol Biol 13, 44-48. 
Kiss-Laszlo, Z., Henry, Y., Bachellerie, J.P., Caizergues-Ferrer, M., and Kiss, T. (1996). 
Site-specific ribose methylation of preribosomal RNA: a novel function for small 
nucleolar RNAs. Cell 85, 1077-1088. 
Kiyosawa, H., Yamanaka, I., Osato, N., Kondo, S., and Hayashizaki, Y. (2003). 
Antisense transcripts with FANTOM2 clone set and their implications for gene 
regulation. Genome Res 13, 1324-1334. 
84 
Kluiver, J., Haralambieva, E., de Jong, D., Blokzijl, T., Jacobs, S., Kroesen, B.J., 
Poppema, S., and van den Berg, A. (2006). Lack of BIC and microRNA miR-155 
expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45, 147-
153. 
Kluiver, J., Poppema, S., de Jong, D., Blokzijl, T., Harms, G., Jacobs, S., Kroesen, B.J., 
and van den Berg, A. (2005). BIC and miR-155 are highly expressed in Hodgkin, primary 
mediastinal and diffuse large B cell lymphomas. J Pathol 207, 243-249. 
Kluiver, J., van den Berg, A., de Jong, D., Blokzijl, T., Harms, G., Bouwman, E., Jacobs, 
S., Poppema, S., and Kroesen, B.J. (2007). Regulation of pri-microRNA BIC 
transcription and processing in Burkitt lymphoma. Oncogene 26, 3769-3776. 
Knight, K.L., and Becker, R.S. (1990). Molecular basis of the allelic inheritance of rabbit 
immunoglobulin VH allotypes: implications for the generation of antibody diversity. Cell 
60, 963-970. 
Komori, J., Marusawa, H., Machimoto, T., Endo, Y., Kinoshita, K., Kou, T., Haga, H., 
Ikai, I., Uemoto, S., and Chiba, T. (2008). Activation-induced cytidine deaminase links 
bile duct inflammation to human cholangiocarcinoma. Hepatology 47, 888-896. 
Krek, A., Grun, D., Poy, M.N., Wolf, R., Rosenberg, L., Epstein, E.J., MacMenamin, P., 
da Piedade, I., Gunsalus, K.C., Stoffel, M., et al. (2005). Combinatorial microRNA target 
predictions. Nat Genet 37, 495-500. 
Krokan, H.E., Drablos, F., and Slupphaug, G. (2002). Uracil in DNA--occurrence, 
consequences and repair. Oncogene 21, 8935-8948. 
Kruger, K., Grabowski, P.J., Zaug, A.J., Sands, J., Gottschling, D.E., and Cech, T.R. 
(1982). Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA 
intervening sequence of Tetrahymena. Cell 31, 147-157. 
Kuo, M.Y., Sharmeen, L., Dinter-Gottlieb, G., and Taylor, J. (1988). Characterization of 
self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta 
virus. J Virol 62, 4439-4444. 
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, 
A., Kamphorst, A.O., Landthaler, M., et al. (2007). A mammalian microRNA expression 
atlas based on small RNA library sequencing. Cell 129, 1401-1414. 
Larijani, M., Petrov, A.P., Kolenchenko, O., Berru, M., Krylov, S.N., and Martin, A. 
(2007). AID associates with single-stranded DNA with high affinity and a long complex 
half-life in a sequence-independent manner. Mol Cell Biol 27, 20-30. 
Larson, E.D., Cummings, W.J., Bednarski, D.W., and Maizels, N. (2005). 
MRE11/RAD50 cleaves DNA in the AID/UNG-dependent pathway of immunoglobulin 
gene diversification. Mol Cell 20, 367-375. 
85 
Lebman, D.A., Nomura, D.Y., Coffman, R.L., and Lee, F.D. (1990). Molecular 
characterization of germ-line immunoglobulin A transcripts produced during 
transforming growth factor type beta-induced isotype switching. Proc Natl Acad Sci U S 
A 87, 3962-3966. 
Lederberg, J. (1959). Genes and antibodies. Science 129, 1649-1653. 
Lee, R.C., Feinbaum, R.L., and Ambros, V. (1993). The C. elegans heterochronic gene 
lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854. 
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Radmark, O., 
Kim, S., et al. (2003). The nuclear RNase III Drosha initiates microRNA processing. 
Nature 425, 415-419. 
Lerner, M.R., Boyle, J.A., Mount, S.M., Wolin, S.L., and Steitz, J.A. (1980). Are snRNPs 
involved in splicing? Nature 283, 220-224. 
Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P., and Burge, C.B. (2003). 
Prediction of mammalian microRNA targets. Cell 115, 787-798. 
Li, Z., Otevrel, T., Gao, Y., Cheng, H.L., Seed, B., Stamato, T.D., Taccioli, G.E., and Alt, 
F.W. (1995). The XRCC4 gene encodes a novel protein involved in DNA double-strand 
break repair and V(D)J recombination. Cell 83, 1079-1089. 
Li, Z., Scherer, S.J., Ronai, D., Iglesias-Ussel, M.D., Peled, J.U., Bardwell, P.D., Zhuang, 
M., Lee, K., Martin, A., Edelmann, W., et al. (2004). Examination of Msh6- and Msh3-
deficient mice in class switching reveals overlapping and distinct roles of MutS 
homologues in antibody diversification. J Exp Med 200, 47-59. 
Lim, L.P., Lau, N.C., Garrett-Engele, P., Grimson, A., Schelter, J.M., Castle, J., Bartel, 
D.P., Linsley, P.S., and Johnson, J.M. (2005). Microarray analysis shows that some 
microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773. 
Liu, J., Carmell, M.A., Rivas, F.V., Marsden, C.G., Thomson, J.M., Song, J.J., 
Hammond, S.M., Joshua-Tor, L., and Hannon, G.J. (2004). Argonaute2 is the catalytic 
engine of mammalian RNAi. Science 305, 1437-1441. 
Liu, M., Duke, J.L., Richter, D.J., Vinuesa, C.G., Goodnow, C.C., Kleinstein, S.H., and 
Schatz, D.G. (2008). Two levels of protection for the B cell genome during somatic 
hypermutation. Nature 451, 841-845. 
Llave, C., Xie, Z., Kasschau, K.D., and Carrington, J.C. (2002). Cleavage of Scarecrow-
like mRNA targets directed by a class of Arabidopsis miRNA. Science 297, 2053-2056. 
Longerich, S., Tanaka, A., Bozek, G., Nicolae, D., and Storb, U. (2005). The very 5' end 
and the constant region of Ig genes are spared from somatic mutation because AID does 
not access these regions. J Exp Med 202, 1443-1454. 
86 
Lorenz, M., Jung, S., and Radbruch, A. (1995). Switch transcripts in immunoglobulin 
class switching. Science 267, 1825-1828. 
Lumsden, J.M., McCarty, T., Petiniot, L.K., Shen, R., Barlow, C., Wynn, T.A., Morse, 
H.C., 3rd, Gearhart, P.J., Wynshaw-Boris, A., Max, E.E., et al. (2004). Immunoglobulin 
class switch recombination is impaired in Atm-deficient mice. J Exp Med 200, 1111-
1121. 
Lutzker, S., and Alt, F.W. (1988). Structure and expression of germ line immunoglobulin 
gamma 2b transcripts. Mol Cell Biol 8, 1849-1852. 
Lutzker, S., Rothman, P., Pollock, R., Coffman, R., and Alt, F.W. (1988). Mitogen- and 
IL-4-regulated expression of germ-line Ig gamma 2b transcripts: evidence for directed 
heavy chain class switching. Cell 53, 177-184. 
MacDuff, D.A., Neuberger, M.S., and Harris, R.S. (2006). MDM2 can interact with the 
C-terminus of AID but it is inessential for antibody diversification in DT40 B cells. Mol 
Immunol 43, 1099-1108. 
Maki, R., Traunecker, A., Sakano, H., Roeder, W., and Tonegawa, S. (1980). Exon 
shuffling generates an immunoglobulin heavy chain gene. Proc Natl Acad Sci U S A 77, 
2138-2142. 
Mandal, M., Boese, B., Barrick, J.E., Winkler, W.C., and Breaker, R.R. (2003). 
Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other 
bacteria. Cell 113, 577-586. 
Mandal, M., Lee, M., Barrick, J.E., Weinberg, Z., Emilsson, G.M., Ruzzo, W.L., and 
Breaker, R.R. (2004). A glycine-dependent riboswitch that uses cooperative binding to 
control gene expression. Science 306, 275-279. 
Manis, J.P., Dudley, D., Kaylor, L., and Alt, F.W. (2002). IgH class switch 
recombination to IgG1 in DNA-PKcs-deficient B cells. Immunity 16, 607-617. 
Manis, J.P., Gu, Y., Lansford, R., Sonoda, E., Ferrini, R., Davidson, L., Rajewsky, K., 
and Alt, F.W. (1998). Ku70 is required for late B cell development and immunoglobulin 
heavy chain class switching. J Exp Med 187, 2081-2089. 
Manis, J.P., Morales, J.C., Xia, Z., Kutok, J.L., Alt, F.W., and Carpenter, P.B. (2004). 
53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-
switch recombination. Nat Immunol 5, 481-487. 
Mansfield, J.H., Harfe, B.D., Nissen, R., Obenauer, J., Srineel, J., Chaudhuri, A., Farzan-
Kashani, R., Zuker, M., Pasquinelli, A.E., Ruvkun, G., et al. (2004). MicroRNA-
responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated 
patterns of vertebrate microRNA expression. Nat Genet 36, 1079-1083. 
87 
Mariner, P.D., Walters, R.D., Espinoza, C.A., Drullinger, L.F., Wagner, S.D., Kugel, J.F., 
and Goodrich, J.A. (2008). Human Alu RNA is a modular transacting repressor of 
mRNA transcription during heat shock. Mol Cell 29, 499-509. 
Martens, J.A., Laprade, L., and Winston, F. (2004). Intergenic transcription is required to 
repress the Saccharomyces cerevisiae SER3 gene. Nature 429, 571-574. 
Martianov, I., Ramadass, A., Serra Barros, A., Chow, N., and Akoulitchev, A. (2007). 
Repression of the human dihydrofolate reductase gene by a non-coding interfering 
transcript. Nature 445, 666-670. 
Martin, A., Li, Z., Lin, D.P., Bardwell, P.D., Iglesias-Ussel, M.D., Edelmann, W., and 
Scharff, M.D. (2003). Msh2 ATPase activity is essential for somatic hypermutation at a-T 
basepairs and for efficient class switch recombination. J Exp Med 198, 1171-1178. 
Martomo, S.A., Yang, W.W., and Gearhart, P.J. (2004). A role for Msh6 but not Msh3 in 
somatic hypermutation and class switch recombination. J Exp Med 200, 61-68. 
Martomo, S.A., Yang, W.W., Wersto, R.P., Ohkumo, T., Kondo, Y., Yokoi, M., 
Masutani, C., Hanaoka, F., and Gearhart, P.J. (2005). Different mutation signatures in 
DNA polymerase eta- and MSH6-deficient mice suggest separate roles in antibody 
diversification. Proc Natl Acad Sci U S A 102, 8656-8661. 
Masuda, K., Ouchida, R., Takeuchi, A., Saito, T., Koseki, H., Kawamura, K., Tagawa, 
M., Tokuhisa, T., Azuma, T., and J, O.W. (2005). DNA polymerase theta contributes to 
the generation of C/G mutations during somatic hypermutation of Ig genes. Proc Natl 
Acad Sci U S A 102, 13986-13991. 
Matsumoto, Y., Marusawa, H., Kinoshita, K., Endo, Y., Kou, T., Morisawa, T., Azuma, 
T., Okazaki, I.M., Honjo, T., and Chiba, T. (2007). Helicobacter pylori infection triggers 
aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat 
Med 13, 470-476. 
Matthias, P., and Rolink, A.G. (2005). Transcriptional networks in developing and 
mature B cells. Nat Rev Immunol 5, 497-508. 
McBlane, J.F., van Gent, D.C., Ramsden, D.A., Romeo, C., Cuomo, C.A., Gellert, M., 
and Oettinger, M.A. (1995). Cleavage at a V(D)J recombination signal requires only 
RAG1 and RAG2 proteins and occurs in two steps. Cell 83, 387-395. 
McBride, K.M., Barreto, V., Ramiro, A.R., Stavropoulos, P., and Nussenzweig, M.C. 
(2004). Somatic hypermutation is limited by CRM1-dependent nuclear export of 
activation-induced deaminase. J Exp Med 199, 1235-1244. 
McBride, K.M., Gazumyan, A., Woo, E.M., Barreto, V.M., Robbiani, D.F., Chait, B.T., 
and Nussenzweig, M.C. (2006). Regulation of hypermutation by activation-induced 
cytidine deaminase phosphorylation. Proc Natl Acad Sci U S A 103, 8798-8803. 
88 
McBride, K.M., Gazumyan, A., Woo, E.M., Schwickert, T.A., Chait, B.T., and 
Nussenzweig, M.C. (2008). Regulation of class switch recombination and somatic 
mutation by AID phosphorylation. J Exp Med 205, 2585-2594. 
Mendel, G. (1866). Experiments on plant hybridization. Versuche über Pflanzen-
Hybriden Verh Naturforsch Ver Brün 4, 3-47. 
Miescher, F. (1869). Letter I; to Wilhelm His. Die Histochemischen und Physiologischen 
Arbeiten von Friedrich Miescher—Aus dem wissenschaftlichen Briefwechsel von F 
Miescher 1, 33-38. 
Misulovin, Z., Yang, X.W., Yu, W., Heintz, N., and Meffre, E. (2001). A rapid method 
for targeted modification and screening of recombinant bacterial artificial chromosome. J 
Immunol Methods 257, 99-105. 
Mizuta, R., Iwai, K., Shigeno, M., Mizuta, M., Uemura, T., Ushiki, T., and Kitamura, D. 
(2003). Molecular visualization of immunoglobulin switch region RNA/DNA complex 
by atomic force microscope. J Biol Chem 278, 4431-4434. 
Moshous, D., Callebaut, I., de Chasseval, R., Corneo, B., Cavazzana-Calvo, M., Le Deist, 
F., Tezcan, I., Sanal, O., Bertrand, Y., Philippe, N., et al. (2001). Artemis, a novel DNA 
double-strand break repair/V(D)J recombination protein, is mutated in human severe 
combined immune deficiency. Cell 105, 177-186. 
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., and Honjo, T. 
(2000). Class switch recombination and hypermutation require activation-induced 
cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563. 
Muramatsu, M., Sankaranand, V.S., Anant, S., Sugai, M., Kinoshita, K., Davidson, N.O., 
and Honjo, T. (1999). Specific expression of activation-induced cytidine deaminase 
(AID), a novel member of the RNA-editing deaminase family in germinal center B cells. 
J Biol Chem 274, 18470-18476. 
Muto, T., Okazaki, I.M., Yamada, S., Tanaka, Y., Kinoshita, K., Muramatsu, M., 
Nagaoka, H., and Honjo, T. (2006). Negative regulation of activation-induced cytidine 
deaminase in B cells. Proc Natl Acad Sci U S A 103, 2752-2757. 
Napoli, C., Lemieux, C., and Jorgensen, R. (1990). Introduction of a Chimeric Chalcone 
Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes 
in trans. Plant Cell 2, 279-289. 
Neil, H., Malabat, C., d'Aubenton-Carafa, Y., Xu, Z., Steinmetz, L.M., and Jacquier, A. 
(2009). Widespread bidirectional promoters are the major source of cryptic transcripts in 
yeast. Nature 457, 1038-1042. 
Nguyen, V.T., Kiss, T., Michels, A.A., and Bensaude, O. (2001). 7SK small nuclear 
RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 414, 322-
325. 
89 
Ni, J., Tien, A.L., and Fournier, M.J. (1997). Small nucleolar RNAs direct site-specific 
synthesis of pseudouridine in ribosomal RNA. Cell 89, 565-573. 
Nielsen, H., Westhof, E., and Johansen, S. (2005). An mRNA is capped by a 2', 5' lariat 
catalyzed by a group I-like ribozyme. Science 309, 1584-1587. 
Nishimoto, N., Kubagawa, H., Ohno, T., Gartland, G.L., Stankovic, A.K., and Cooper, 
M.D. (1991). Normal pre-B cells express a receptor complex of mu heavy chains and 
surrogate light-chain proteins. Proc Natl Acad Sci U S A 88, 6284-6288. 
O'Connell, R.M., Rao, D.S., Chaudhuri, A.A., Boldin, M.P., Taganov, K.D., Nicoll, J., 
Paquette, R.L., and Baltimore, D. (2008). Sustained expression of microRNA-155 in 
hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 205, 585-594. 
O'Connell, R.M., Taganov, K.D., Boldin, M.P., Cheng, G., and Baltimore, D. (2007). 
MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl 
Acad Sci U S A 104, 1604-1609. 
O'Donnell, K.A., and Boeke, J.D. (2007). Mighty Piwis defend the germline against 
genome intruders. Cell 129, 37-44. 
Odegard, V.H., and Schatz, D.G. (2006). Targeting of somatic hypermutation. Nat Rev 
Immunol 6, 573-583. 
Okazaki, Y., Furuno, M., Kasukawa, T., Adachi, J., Bono, H., Kondo, S., Nikaido, I., 
Osato, N., Saito, R., Suzuki, H., et al. (2002). Analysis of the mouse transcriptome based 
on functional annotation of 60,770 full-length cDNAs. Nature 420, 563-573. 
Omer, A.D., Lowe, T.M., Russell, A.G., Ebhardt, H., Eddy, S.R., and Dennis, P.P. 
(2000). Homologs of small nucleolar RNAs in Archaea. Science 288, 517-522. 
Osato, N., Suzuki, Y., Ikeo, K., and Gojobori, T. (2007). Transcriptional interferences in 
cis natural antisense transcripts of humans and mice. Genetics 176, 1299-1306. 
Pandey, R.R., Mondal, T., Mohammad, F., Enroth, S., Redrup, L., Komorowski, J., 
Nagano, T., Mancini-Dinardo, D., and Kanduri, C. (2008). Kcnq1ot1 antisense 
noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-
level regulation. Mol Cell 32, 232-246. 
Panning, B., Dausman, J., and Jaenisch, R. (1997). X chromosome inactivation is 
mediated by Xist RNA stabilization. Cell 90, 907-916. 
Panning, B., and Jaenisch, R. (1996). DNA hypomethylation can activate Xist expression 
and silence X-linked genes. Genes Dev 10, 1991-2002. 
Park, S.R., Zan, H., Pal, Z., Zhang, J., Al-Qahtani, A., Pone, E.J., Xu, Z., Mai, T., and 
Casali, P. (2009). HoxC4 binds to the promoter of the cytidine deaminase AID gene to 
90 
induce AID expression, class-switch DNA recombination and somatic hypermutation. 
Nat Immunol. 
Pasqualucci, L., Kitaura, Y., Gu, H., and Dalla-Favera, R. (2006). PKA-mediated 
phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. 
Proc Natl Acad Sci U S A 103, 395-400. 
Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R.S., Kuppers, 
R., and Dalla-Favera, R. (2001). Hypermutation of multiple proto-oncogenes in B-cell 
diffuse large-cell lymphomas. Nature 412, 341-346. 
Pauklin, S., Sernandez, I.V., Bachmann, G., Ramiro, A.R., and Petersen-Mahrt, S.K. 
(2009). Estrogen directly activates AID transcription and function. J Exp Med 206, 99-
111. 
Perlot, T., Li, G., and Alt, F.W. (2008). Antisense transcripts from immunoglobulin 
heavy-chain locus V(D)J and switch regions. Proc Natl Acad Sci U S A 105, 3843-3848. 
Peters, A., and Storb, U. (1996). Somatic hypermutation of immunoglobulin genes is 
linked to transcription initiation. Immunity 4, 57-65. 
Petersen, S., Casellas, R., Reina-San-Martin, B., Chen, H.T., Difilippantonio, M.J., 
Wilson, P.C., Hanitsch, L., Celeste, A., Muramatsu, M., Pilch, D.R., et al. (2001). AID is 
required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class 
switching. Nature 414, 660-665. 
Pham, P., Bransteitter, R., Petruska, J., and Goodman, M.F. (2003). Processive AID-
catalysed cytosine deamination on single-stranded DNA simulates somatic 
hypermutation. Nature 424, 103-107. 
Phung, Q.H., Winter, D.B., Cranston, A., Tarone, R.E., Bohr, V.A., Fishel, R., and 
Gearhart, P.J. (1998). Increased hypermutation at G and C nucleotides in 
immunoglobulin variable genes from mice deficient in the MSH2 mismatch repair 
protein. J Exp Med 187, 1745-1751. 
Preker, P., Nielsen, J., Kammler, S., Lykke-Andersen, S., Christensen, M.S., Mapendano, 
C.K., Schierup, M.H., and Jensen, T.H. (2008). RNA exosome depletion reveals 
transcription upstream of active human promoters. Science 322, 1851-1854. 
Qiu, G., Harriman, G.R., and Stavnezer, J. (1999). Ialpha exon-replacement mice 
synthesize a spliced HPRT-C(alpha) transcript which may explain their ability to switch 
to IgA. Inhibition of switching to IgG in these mice. Int Immunol 11, 37-46. 
Rada, C., Ehrenstein, M.R., Neuberger, M.S., and Milstein, C. (1998). Hot spot focusing 
of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational 
targeting. Immunity 9, 135-141. 
91 
Rada, C., and Milstein, C. (2001). The intrinsic hypermutability of antibody heavy and 
light chain genes decays exponentially. Embo J 20, 4570-4576. 
Rada, C., Williams, G.T., Nilsen, H., Barnes, D.E., Lindahl, T., and Neuberger, M.S. 
(2002). Immunoglobulin isotype switching is inhibited and somatic hypermutation 
perturbed in UNG-deficient mice. Curr Biol 12, 1748-1755. 
Radcliffe, G., Lin, Y.C., Julius, M., Marcu, K.B., and Stavnezer, J. (1990). Structure of 
germ line immunoglobulin alpha heavy-chain RNA and its location on polysomes. Mol 
Cell Biol 10, 382-386. 
Ramiro, A.R., Jankovic, M., Callen, E., Difilippantonio, S., Chen, H.T., McBride, K.M., 
Eisenreich, T.R., Chen, J., Dickins, R.A., Lowe, S.W., et al. (2006). Role of genomic 
instability and p53 in AID-induced c-myc-Igh translocations. Nature 440, 105-109. 
Ramiro, A.R., Jankovic, M., Eisenreich, T., Difilippantonio, S., Chen-Kiang, S., 
Muramatsu, M., Honjo, T., Nussenzweig, A., and Nussenzweig, M.C. (2004). AID is 
required for c-myc/IgH chromosome translocations in vivo. Cell 118, 431-438. 
Reaban, M.E., and Griffin, J.A. (1990). Induction of RNA-stabilized DNA conformers by 
transcription of an immunoglobulin switch region. Nature 348, 342-344. 
Reaban, M.E., Lebowitz, J., and Griffin, J.A. (1994). Transcription induces the formation 
of a stable RNA.DNA hybrid in the immunoglobulin alpha switch region. J Biol Chem 
269, 21850-21857. 
Reina-San-Martin, B., Chen, H.T., Nussenzweig, A., and Nussenzweig, M.C. (2004). 
ATM is required for efficient recombination between immunoglobulin switch regions. J 
Exp Med 200, 1103-1110. 
Reina-San-Martin, B., Difilippantonio, S., Hanitsch, L., Masilamani, R.F., Nussenzweig, 
A., and Nussenzweig, M.C. (2003). H2AX is required for recombination between 
immunoglobulin switch regions but not for intra-switch region recombination or somatic 
hypermutation. J Exp Med 197, 1767-1778. 
Reina-San-Martin, B., Nussenzweig, M.C., Nussenzweig, A., and Difilippantonio, S. 
(2005). Genomic instability, endoreduplication, and diminished Ig class-switch 
recombination in B cells lacking Nbs1. Proc Natl Acad Sci U S A 102, 1590-1595. 
Reinhart, B.J., and Bartel, D.P. (2002). Small RNAs correspond to centromere 
heterochromatic repeats. Science 297, 1831. 
Reth, M., Petrac, E., Wiese, P., Lobel, L., and Alt, F.W. (1987). Activation of V kappa 
gene rearrangement in pre-B cells follows the expression of membrane-bound 
immunoglobulin heavy chains. Embo J 6, 3299-3305. 
Revy, P., Muto, T., Levy, Y., Geissmann, F., Plebani, A., Sanal, O., Catalan, N., 
Forveille, M., Dufourcq-Labelouse, R., Gennery, A., et al. (2000). Activation-induced 
92 
cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-
IgM syndrome (HIGM2). Cell 102, 565-575. 
Reynaud, C.A., Anquez, V., Dahan, A., and Weill, J.C. (1985). A single rearrangement 
event generates most of the chicken immunoglobulin light chain diversity. Cell 40, 283-
291. 
Reynaud, C.A., Anquez, V., Grimal, H., and Weill, J.C. (1987). A hyperconversion 
mechanism generates the chicken light chain preimmune repertoire. Cell 48, 379-388. 
Reynaud, C.A., Dahan, A., Anquez, V., and Weill, J.C. (1989). Somatic hyperconversion 
diversifies the single Vh gene of the chicken with a high incidence in the D region. Cell 
59, 171-183. 
Rhoades, M.W., Reinhart, B.J., Lim, L.P., Burge, C.B., Bartel, B., and Bartel, D.P. 
(2002). Prediction of plant microRNA targets. Cell 110, 513-520. 
Rinn, J.L., Kertesz, M., Wang, J.K., Squazzo, S.L., Xu, X., Brugmann, S.A., Goodnough, 
L.H., Helms, J.A., Farnham, P.J., Segal, E., et al. (2007). Functional demarcation of 
active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 
1311-1323. 
Robbiani, D.F., Bothmer, A., Callen, E., Reina-San-Martin, B., Dorsett, Y., 
Difilippantonio, S., Bolland, D.J., Chen, H.T., Corcoran, A.E., Nussenzweig, A., et al. 
(2008). AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH 
translocations. Cell 135, 1028-1038. 
Rodriguez, A., Vigorito, E., Clare, S., Warren, M.V., Couttet, P., Soond, D.R., van 
Dongen, S., Grocock, R.J., Das, P.P., Miska, E.A., et al. (2007). Requirement of 
bic/microRNA-155 for normal immune function. Science 316, 608-611. 
Rogers, J., and Wall, R. (1980). A mechanism for RNA splicing. Proc Natl Acad Sci U S 
A 77, 1877-1879. 
Rogozin, I.B., and Kolchanov, N.A. (1992). Somatic hypermutagenesis in 
immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. 
Biochim Biophys Acta 1171, 11-18. 
Romano, N., and Macino, G. (1992). Quelling: transient inactivation of gene expression 
in Neurospora crassa by transformation with homologous sequences. Mol Microbiol 6, 
3343-3353. 
Rothman, P., Chen, Y.Y., Lutzker, S., Li, S.C., Stewart, V., Coffman, R., and Alt, F.W. 
(1990a). Structure and expression of germ line immunoglobulin heavy-chain epsilon 
transcripts: interleukin-4 plus lipopolysaccharide-directed switching to C epsilon. Mol 
Cell Biol 10, 1672-1679. 
93 
Rothman, P., Lutzker, S., Gorham, B., Stewart, V., Coffman, R., and Alt, F.W. (1990b). 
Structure and expression of germline immunoglobulin gamma 3 heavy chain gene 
transcripts: implications for mitogen and lymphokine directed class-switching. Int 
Immunol 2, 621-627. 
Sakano, H., Kurosawa, Y., Weigert, M., and Tonegawa, S. (1981). Identification and 
nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain 
genes. Nature 290, 562-565. 
Salehi-Ashtiani, K., Luptak, A., Litovchick, A., and Szostak, J.W. (2006). A genomewide 
search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene. Science 
313, 1788-1792. 
Saville, B.J., and Collins, R.A. (1990). A site-specific self-cleavage reaction performed 
by a novel RNA in Neurospora mitochondria. Cell 61, 685-696. 
Sayegh, C.E., Quong, M.W., Agata, Y., and Murre, C. (2003). E-proteins directly 
regulate expression of activation-induced deaminase in mature B cells. Nat Immunol 4, 
586-593. 
Schatz, D.G., and Baltimore, D. (1988). Stable expression of immunoglobulin gene 
V(D)J recombinase activity by gene transfer into 3T3 fibroblasts. Cell 53, 107-115. 
Schatz, D.G., Oettinger, M.A., and Baltimore, D. (1989). The V(D)J recombination 
activating gene, RAG-1. Cell 59, 1035-1048. 
Schrader, C.E., Bradley, S.P., Vardo, J., Mochegova, S.N., Flanagan, E., and Stavnezer, 
J. (2003). Mutations occur in the Ig Smu region but rarely in Sgamma regions prior to 
class switch recombination. Embo J 22, 5893-5903. 
Schrader, C.E., Edelmann, W., Kucherlapati, R., and Stavnezer, J. (1999). Reduced 
isotype switching in splenic B cells from mice deficient in mismatch repair enzymes. J 
Exp Med 190, 323-330. 
Schrader, C.E., Guikema, J.E., Linehan, E.K., Selsing, E., and Stavnezer, J. (2007). 
Activation-induced cytidine deaminase-dependent DNA breaks in class switch 
recombination occur during G1 phase of the cell cycle and depend upon mismatch repair. 
J Immunol 179, 6064-6071. 
Schrader, C.E., Linehan, E.K., Mochegova, S.N., Woodland, R.T., and Stavnezer, J. 
(2005). Inducible DNA breaks in Ig S regions are dependent on AID and UNG. J Exp 
Med 202, 561-568. 
Seila, A.C., Calabrese, J.M., Levine, S.S., Yeo, G.W., Rahl, P.B., Flynn, R.A., Young, 
R.A., and Sharp, P.A. (2008). Divergent transcription from active promoters. Science 
322, 1849-1851. 
94 
Sernandez, I.V., de Yebenes, V.G., Dorsett, Y., and Ramiro, A.R. (2008). 
Haploinsufficiency of activation-induced deaminase for antibody diversification and 
chromosome translocations both in vitro and in vivo. PLoS ONE 3, e3927. 
Shamovsky, I., Ivannikov, M., Kandel, E.S., Gershon, D., and Nudler, E. (2006). RNA-
mediated response to heat shock in mammalian cells. Nature 440, 556-560. 
Shen, H.M., Peters, A., Baron, B., Zhu, X., and Storb, U. (1998). Mutation of BCL-6 
gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280, 
1750-1752. 
Shen, H.M., and Storb, U. (2004). Activation-induced cytidine deaminase (AID) can 
target both DNA strands when the DNA is supercoiled. Proc Natl Acad Sci U S A 101, 
12997-13002. 
Shi, Y., Di Giammartino, D.C., Taylor, D., Sarkeshik, A., Rice, W.J., Yates, J.R., 3rd, 
Frank, J., and Manley, J.L. (2009). Molecular architecture of the human pre-mRNA 3' 
processing complex. Mol Cell 33, 365-376. 
Shippen-Lentz, D., and Blackburn, E.H. (1990). Functional evidence for an RNA 
template in telomerase. Science 247, 546-552. 
Skalsky, R.L., Samols, M.A., Plaisance, K.B., Boss, I.W., Riva, A., Lopez, M.C., Baker, 
H.V., and Renne, R. (2007). Kaposi's sarcoma-associated herpesvirus encodes an 
ortholog of miR-155. J Virol 81, 12836-12845. 
Sleutels, F., Zwart, R., and Barlow, D.P. (2002). The non-coding Air RNA is required for 
silencing autosomal imprinted genes. Nature 415, 810-813. 
Soulas-Sprauel, P., Le Guyader, G., Rivera-Munoz, P., Abramowski, V., Olivier-Martin, 
C., Goujet-Zalc, C., Charneau, P., and de Villartay, J.P. (2007). Role for DNA repair 
factor XRCC4 in immunoglobulin class switch recombination. J Exp Med 204, 1717-
1727. 
Stavnezer, J., Radcliffe, G., Lin, Y.C., Nietupski, J., Berggren, L., Sitia, R., and 
Severinson, E. (1988). Immunoglobulin heavy-chain switching may be directed by prior 
induction of transcripts from constant-region genes. Proc Natl Acad Sci U S A 85, 7704-
7708. 
Stavnezer, J., and Schrader, C.E. (2006). Mismatch repair converts AID-instigated nicks 
to double-strand breaks for antibody class-switch recombination. Trends Genet 22, 23-28. 
Stavnezer-Nordgren, J., and Sirlin, S. (1986). Specificity of immunoglobulin heavy chain 
switch correlates with activity of germline heavy chain genes prior to switching. Embo J 
5, 95-102. 
Struhl, K. (2007). Transcriptional noise and the fidelity of initiation by RNA polymerase 
II. Nat Struct Mol Biol 14, 103-105. 
95 
Sudarsan, N., Wickiser, J.K., Nakamura, S., Ebert, M.S., and Breaker, R.R. (2003). An 
mRNA structure in bacteria that controls gene expression by binding lysine. Genes Dev 
17, 2688-2697. 
Ta, V.T., Nagaoka, H., Catalan, N., Durandy, A., Fischer, A., Imai, K., Nonoyama, S., 
Tashiro, J., Ikegawa, M., Ito, S., et al. (2003). AID mutant analyses indicate requirement 
for class-switch-specific cofactors. Nat Immunol 4, 843-848. 
Taccioli, G.E., Rathbun, G., Oltz, E., Stamato, T., Jeggo, P.A., and Alt, F.W. (1993). 
Impairment of V(D)J recombination in double-strand break repair mutants. Science 260, 
207-210. 
Taketani, M., Naitoh, A., Motoyama, N., and Azuma, T. (1995). Role of conserved 
amino acid residues in the complementarity determining regions on hapten-antibody 
interaction of anti-(4-hydroxy-3-nitrophenyl) acetyl antibodies. Mol Immunol 32, 983-
990. 
Takizawa, M., Tolarova, H., Li, Z., Dubois, W., Lim, S., Callen, E., Franco, S., Mosaico, 
M., Feigenbaum, L., Alt, F.W., et al. (2008). AID expression levels determine the extent 
of cMyc oncogenic translocations and the incidence of B cell tumor development. J Exp 
Med 205, 1949-1957. 
Talmage, D.W. (1957). Allergy and immunology. Annu Rev Med 41, 849-857. 
Tam, W. (2001). Identification and characterization of human BIC, a gene on 
chromosome 21 that encodes a noncoding RNA. Gene 274, 157-167. 
Tam, W., Ben-Yehuda, D., and Hayward, W.S. (1997). bic, a novel gene activated by 
proviral insertions in avian leukosis virus-induced lymphomas, is likely to function 
through its noncoding RNA. Mol Cell Biol 17, 1490-1502. 
Teixeira, A., Tahiri-Alaoui, A., West, S., Thomas, B., Ramadass, A., Martianov, I., Dye, 
M., James, W., Proudfoot, N.J., and Akoulitchev, A. (2004). Autocatalytic RNA cleavage 
in the human beta-globin pre-mRNA promotes transcription termination. Nature 432, 
526-530. 
Teng, G., Hakimpour, P., Landgraf, P., Rice, A., Tuschl, T., Casellas, R., and 
Papavasiliou, F.N. (2008). MicroRNA-155 is a negative regulator of activation-induced 
cytidine deaminase. Immunity 28, 621-629. 
Thai, T.H., Calado, D.P., Casola, S., Ansel, K.M., Xiao, C., Xue, Y., Murphy, A., 
Frendewey, D., Valenzuela, D., Kutok, J.L., et al. (2007). Regulation of the germinal 
center response by microRNA-155. Science 316, 604-608. 
Thompson, C.B., and Neiman, P.E. (1987). Somatic diversification of the chicken 
immunoglobulin light chain gene is limited to the rearranged variable gene segment. Cell 
48, 369-378. 
96 
Tili, E., Michaille, J.J., Cimino, A., Costinean, S., Dumitru, C.D., Adair, B., Fabbri, M., 
Alder, H., Liu, C.G., Calin, G.A., et al. (2007). Modulation of miR-155 and miR-125b 
levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in 
regulating the response to endotoxin shock. J Immunol 179, 5082-5089. 
Tonegawa, S. (1983). Somatic generation of antibody diversity. Nature 302, 575-581. 
Tycowski, K.T., You, Z.H., Graham, P.J., and Steitz, J.A. (1998). Modification of U6 
spliceosomal RNA is guided by other small RNAs. Mol Cell 2, 629-638. 
Uhler, J.P., Hertel, C., and Svejstrup, J.Q. (2007). A role for noncoding transcription in 
activation of the yeast PHO5 gene. Proc Natl Acad Sci U S A 104, 8011-8016. 
Vagin, V.V., Sigova, A., Li, C., Seitz, H., Gvozdev, V., and Zamore, P.D. (2006). A 
distinct small RNA pathway silences selfish genetic elements in the germline. Science 
313, 320-324. 
van den Berg, A., Kroesen, B.J., Kooistra, K., de Jong, D., Briggs, J., Blokzijl, T., Jacobs, 
S., Kluiver, J., Diepstra, A., Maggio, E., et al. (2003). High expression of B-cell receptor 
inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 
37, 20-28. 
van Gent, D.C., McBlane, J.F., Ramsden, D.A., Sadofsky, M.J., Hesse, J.E., and Gellert, 
M. (1995). Initiation of V(D)J recombination in a cell-free system. Cell 81, 925-934. 
Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., Smith, 
H.O., Yandell, M., Evans, C.A., Holt, R.A., et al. (2001). The sequence of the human 
genome. Science 291, 1304-1351. 
Verdel, A., Jia, S., Gerber, S., Sugiyama, T., Gygi, S., Grewal, S.I., and Moazed, D. 
(2004). RNAi-mediated targeting of heterochromatin by the RITS complex. Science 303, 
672-676. 
Vigorito, E., Perks, K.L., Abreu-Goodger, C., Bunting, S., Xiang, Z., Kohlhaas, S., Das, 
P.P., Miska, E.A., Rodriguez, A., Bradley, A., et al. (2007a). microRNA-155 Regulates 
the Generation of Immunoglobulin Class-Switched Plasma Cells. Immunity. 
Vigorito, E., Perks, K.L., Abreu-Goodger, C., Bunting, S., Xiang, Z., Kohlhaas, S., Das, 
P.P., Miska, E.A., Rodriguez, A., Bradley, A., et al. (2007b). microRNA-155 regulates 
the generation of immunoglobulin class-switched plasma cells. Immunity 27, 847-859. 
Volinia, S., Calin, G.A., Liu, C.G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., 
Iorio, M., Roldo, C., Ferracin, M., et al. (2006). A microRNA expression signature of 
human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103, 2257-
2261. 
97 
Volpe, T., Schramke, V., Hamilton, G.L., White, S.A., Teng, G., Martienssen, R.A., and 
Allshire, R.C. (2003). RNA interference is required for normal centromere function in 
fission yeast. Chromosome Res 11, 137-146. 
Volpe, T.A., Kidner, C., Hall, I.M., Teng, G., Grewal, S.I., and Martienssen, R.A. (2002). 
Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. 
Science 297, 1833-1837. 
Vuong, B.Q., Lee, M., Kabir, S., Irimia, C., Macchiarulo, S., McKnight, G.S., and 
Chaudhuri, J. (2009). Specific recruitment of protein kinase A to the immunoglobulin 
locus regulates class-switch recombination. Nat Immunol. 
Wagner, S.D., Milstein, C., and Neuberger, M.S. (1995). Codon bias targets mutation. 
Nature 376, 732. 
Wakatsuki, Y., and Strober, W. (1993). Effect of downregulation of germline transcripts 
on immunoglobulin A isotype differentiation. J Exp Med 178, 129-138. 
Walter, P., and Blobel, G. (1982). Signal recognition particle contains a 7S RNA 
essential for protein translocation across the endoplasmic reticulum. Nature 299, 691-
698. 
Wang, X., Arai, S., Song, X., Reichart, D., Du, K., Pascual, G., Tempst, P., Rosenfeld, 
M.G., Glass, C.K., and Kurokawa, R. (2008). Induced ncRNAs allosterically modify 
RNA-binding proteins in cis to inhibit transcription. Nature 454, 126-130. 
Ward, I.M., Reina-San-Martin, B., Olaru, A., Minn, K., Tamada, K., Lau, J.S., Cascalho, 
M., Chen, L., Nussenzweig, A., Livak, F., et al. (2004). 53BP1 is required for class 
switch recombination. J Cell Biol 165, 459-464. 
Wassarman, K.M., and Storz, G. (2000). 6S RNA regulates E. coli RNA polymerase 
activity. Cell 101, 613-623. 
Watson, J.D. (1965). The molecular biology of the gene (New York, Benjamin Inc). 
Watson, J.D., and Crick, F.H. (1953). Molecular structure of nucleic acids; a structure for 
deoxyribose nucleic acid. Nature 171, 737-738. 
Wiesendanger, M., Kneitz, B., Edelmann, W., and Scharff, M.D. (2000). Somatic 
hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice 
reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution 
pattern. J Exp Med 191, 579-584. 
Wightman, B., Ha, I., and Ruvkun, G. (1993). Posttranscriptional regulation of the 
heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. 
Cell 75, 855-862. 
98 
Wilkins, M.H., Stokes, A.R., and Wilson, H.R. (1953). Molecular structure of 
deoxypentose nucleic acids. Nature 171, 738-740. 
Willingham, A.T., Orth, A.P., Batalov, S., Peters, E.C., Wen, B.G., Aza-Blanc, P., 
Hogenesch, J.B., and Schultz, P.G. (2005). A strategy for probing the function of 
noncoding RNAs finds a repressor of NFAT. Science 309, 1570-1573. 
Wilson, T.M., Vaisman, A., Martomo, S.A., Sullivan, P., Lan, L., Hanaoka, F., Yasui, A., 
Woodgate, R., and Gearhart, P.J. (2005). MSH2-MSH6 stimulates DNA polymerase eta, 
suggesting a role for A:T mutations in antibody genes. J Exp Med 201, 637-645. 
Winkler, W., Nahvi, A., and Breaker, R.R. (2002a). Thiamine derivatives bind messenger 
RNAs directly to regulate bacterial gene expression. Nature 419, 952-956. 
Winkler, W.C., Cohen-Chalamish, S., and Breaker, R.R. (2002b). An mRNA structure 
that controls gene expression by binding FMN. Proc Natl Acad Sci U S A 99, 15908-
15913. 
Winkler, W.C., Nahvi, A., Sudarsan, N., Barrick, J.E., and Breaker, R.R. (2003). An 
mRNA structure that controls gene expression by binding S-adenosylmethionine. Nat 
Struct Biol 10, 701-707. 
Winter, D.B., Phung, Q.H., Umar, A., Baker, S.M., Tarone, R.E., Tanaka, K., Liskay, 
R.M., Kunkel, T.A., Bohr, V.A., and Gearhart, P.J. (1998). Altered spectra of 
hypermutation in antibodies from mice deficient for the DNA mismatch repair protein 
PMS2. Proc Natl Acad Sci U S A 95, 6953-6958. 
Woese, C.R. (1967). The genetic code (New York, Harper & Row). 
Wroe, S.F., Kelsey, G., Skinner, J.A., Bodle, D., Ball, S.T., Beechey, C.V., Peters, J., and 
Williamson, C.M. (2000). An imprinted transcript, antisense to Nesp, adds complexity to 
the cluster of imprinted genes at the mouse Gnas locus. Proc Natl Acad Sci U S A 97, 
3342-3346. 
Wyers, F., Rougemaille, M., Badis, G., Rousselle, J.C., Dufour, M.E., Boulay, J., 
Regnault, B., Devaux, F., Namane, A., Seraphin, B., et al. (2005). Cryptic pol II 
transcripts are degraded by a nuclear quality control pathway involving a new poly(A) 
polymerase. Cell 121, 725-737. 
Xiao, C., Calado, D.P., Galler, G., Thai, T.H., Patterson, H.C., Wang, J., Rajewsky, N., 
Bender, T.P., and Rajewsky, K. (2007). MiR-150 controls B cell differentiation by 
targeting the transcription factor c-Myb. Cell 131, 146-159. 
Xu, L., Gorham, B., Li, S.C., Bottaro, A., Alt, F.W., and Rothman, P. (1993). 
Replacement of germ-line epsilon promoter by gene targeting alters control of 
immunoglobulin heavy chain class switching. Proc Natl Acad Sci U S A 90, 3705-3709. 
99 
Xu, M., and Stavnezer, J. (1990). Structure of germline immunoglobulin heavy-chain 
gamma 1 transcripts in interleukin 4 treated mouse spleen cells. Dev Immunol 1, 11-17. 
Xu, Z., Wei, W., Gagneur, J., Perocchi, F., Clauder-Munster, S., Camblong, J., Guffanti, 
E., Stutz, F., Huber, W., and Steinmetz, L.M. (2009). Bidirectional promoters generate 
pervasive transcription in yeast. Nature 457, 1033-1037. 
Yabuki, M., Fujii, M.M., and Maizels, N. (2005). The MRE11-RAD50-NBS1 complex 
accelerates somatic hypermutation and gene conversion of immunoglobulin variable 
regions. Nat Immunol 6, 730-736. 
Yan, C.T., Boboila, C., Souza, E.K., Franco, S., Hickernell, T.R., Murphy, M., Gumaste, 
S., Geyer, M., Zarrin, A.A., Manis, J.P., et al. (2007). IgH class switching and 
translocations use a robust non-classical end-joining pathway. Nature 449, 478-482. 
Yang, Z., Zhu, Q., Luo, K., and Zhou, Q. (2001). The 7SK small nuclear RNA inhibits 
the CDK9/cyclin T1 kinase to control transcription. Nature 414, 317-322. 
Yekta, S., Shih, I.H., and Bartel, D.P. (2004). MicroRNA-directed cleavage of HOXB8 
mRNA. Science 304, 594-596. 
Yelin, R., Dahary, D., Sorek, R., Levanon, E.Y., Goldstein, O., Shoshan, A., Diber, A., 
Biton, S., Tamir, Y., Khosravi, R., et al. (2003). Widespread occurrence of antisense 
transcription in the human genome. Nat Biotechnol 21, 379-386. 
Yin, Q., McBride, J., Fewell, C., Lacey, M., Wang, X., Lin, Z., Cameron, J., and 
Flemington, E.K. (2008a). MicroRNA-155 is an Epstein-Barr virus-induced gene that 
modulates Epstein-Barr virus-regulated gene expression pathways. J Virol 82, 5295-
5306. 
Yin, Q., Wang, X., McBride, J., Fewell, C., and Flemington, E. (2008b). B-cell receptor 
activation induces BIC/miR-155 expression through a conserved AP-1 element. J Biol 
Chem 283, 2654-2662. 
Yu, K., Chedin, F., Hsieh, C.L., Wilson, T.E., and Lieber, M.R. (2003). R-loops at 
immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat 
Immunol 4, 442-451. 
Yu, Z., Jian, Z., Shen, S.H., Purisima, E., and Wang, E. (2007). Global analysis of 
microRNA target gene expression reveals that miRNA targets are lower expressed in 
mature mouse and Drosophila tissues than in the embryos. Nucleic Acids Res 35, 152-
164. 
Zamore, P.D., Tuschl, T., Sharp, P.A., and Bartel, D.P. (2000). RNAi: double-stranded 
RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 
101, 25-33. 
100 
Zan, H., Komori, A., Li, Z., Cerutti, A., Schaffer, A., Flajnik, M.F., Diaz, M., and Casali, 
P. (2001). The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 
somatic hypermutation. Immunity 14, 643-653. 
Zan, H., Shima, N., Xu, Z., Al-Qahtani, A., Evinger Iii, A.J., Zhong, Y., Schimenti, J.C., 
and Casali, P. (2005). The translesion DNA polymerase theta plays a dominant role in 
immunoglobulin gene somatic hypermutation. Embo J 24, 3757-3769. 
Zeng, X., Negrete, G.A., Kasmer, C., Yang, W.W., and Gearhart, P.J. (2004). Absence of 
DNA polymerase eta reveals targeting of C mutations on the nontranscribed strand in 
immunoglobulin switch regions. J Exp Med 199, 917-924. 
Zhang, J., Bottaro, A., Li, S., Stewart, V., and Alt, F.W. (1993). A selective defect in 
IgG2b switching as a result of targeted mutation of the I gamma 2b promoter and exon. 
Embo J 12, 3529-3537. 
Zhou, Z., Licklider, L.J., Gygi, S.P., and Reed, R. (2002). Comprehensive proteomic 
analysis of the human spliceosome. Nature 419, 182-185. 
Zilberman, D., Cao, X., and Jacobsen, S.E. (2003). ARGONAUTE4 control of locus-
specific siRNA accumulation and DNA and histone methylation. Science 299, 716-719. 
 
 
